Benzodiazepine use

RX_BZD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N05BA 1 out of 7 registries used, show all original rules.	65064
4. Check minimum number of events Min. number of events 3	65064
5. Include endpoints None	65064
6. Filter based on genotype QC (FinnGen only)	62915

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_BZD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N05BA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benzodiazepine use based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62915	38486	24429
Unadjusted period prevalence (%)	12.70	13.65	11.19
Median age at first event (years)	46.63	44.83	49.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
63490: Matched controls
436919

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.2

322.1

1432

3099

N03AX14

ATC

levetiracetam; systemic

2.9

320.6

1716

4150

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

318.2

29684

169589

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

12.3

317.3

393

222

H02AB07

ATC

prednisone; oral

1.7

317.1

7348

31611

ZXD05

NOMESCO Finland

Urgent procedure

1.4

316.2

16846

87259

G47.3

ICD-10 Finland

Sleep apnoea

1.5

316.0

12015

58164

F20.8

ICD-10 Finland

Other schizophrenia

13.4

316.0

373

192

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

314.9

21845

118656

T90

ICPC

Diabetes non-insulin dependent

1.5

314.2

11811

57028

N02AC04

ATC

dextropropoxyphene; oral

2.6

312.9

1996

5307

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

6.1

311.8

633

716

F60.2

ICD-10 Finland

Dissocial personality disorder

17.3

311.6

328

131

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

28.9

310.7

276

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

13.8

310.3

362

182

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

8.2

307.7

2410

2103

M01AH01

ATC

celecoxib; oral

1.6

307.7

9498

42153

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

5.9

307.7

2265

2728

L01

ICPC

Neck symptom/complaint

1.7

307.7

8608

37559

V03AB30, ,

ATC

8.3

307.7

553

461

IER01

NOMESCO Finland

Psychoeducation, group

8.8

307.7

651

515

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.9

307.7

3343

3500

A01

ICPC

Pain general/multiple sites

2.4

307.7

5863

17745

A01AB09

ATC

miconazole; local oral

2.1

307.7

4974

17001

N05AB03

ATC

perphenazine; systemic, rectal

12.3

307.7

4688

2809

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

307.7

20028

105416

T74.1

ICD-10 Finland

Physical abuse

3.6

307.7

1324

2597

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

7.1

307.7

2400

N05BA12

ATC

alprazolam; oral

22.5

307.7

18537

7869

J01AA02

ATC

doxycycline; systemic

1.6

307.7

45933

271481

IEV99

NOMESCO Finland

Other psychiatric network intervention

9.9

307.7

475

333

N05BE01

ATC

buspirone; oral

20.1

307.7

4555

1675

30041

ICD-8 Finland

Neuroses, Depressiva

5.2

307.7

780

1039

N06AX11

ATC

mirtazapine; oral

5.8

307.7

36055

80864

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.2

307.7

2208

4829

N03AG01

ATC

valproic acid; systemic, rectal

8.3

307.7

7842

7315

IGV01

NOMESCO Finland

Psychiatric network contact

10.0

307.7

936

656

IGY02, ,

SPAT

6.7

307.7

1091

1145

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

307.7

2421

6557

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

307.7

3428

9057

N05AB02

ATC

fluphenazine; systemic

12.5

307.7

527

293

P99

ICPC

Psychological disorders other

6.9

307.7

3222

3359

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

14145

53840

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.3

307.7

4546

10003

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

307.7

12169

57381

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

307.7

7622

32370

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

18.7

307.7

761

283

SPAT1301

SPAT

No procedures

1.5

307.7

17659

87247

Z3226

NOMESCO Finland

Physiotherapist

1.7

307.7

10061

43590

D11

ICPC

Diarrhoea

1.7

307.7

6815

28154

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

307.7

20186

103264

C08CA01

ATC

amlodipine; oral

1.5

307.7

19442

100117

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

307.7

7209

28875

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

7.3

307.7

2627

2580

F41.1

ICD-10 Finland

Generalized anxiety disorder

6.1

307.7

6103

7439

N06AX05

ATC

trazodone; oral

11.3

307.7

3221

2050

SPAT1260

SPAT

Consultation of another employee

1.6

307.7

9735

43804

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

31920

177383

A02BA02

ATC

ranitidine; systemic

2.3

307.7

12533

42935

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

307.7

1958

4891

N06AA04

ATC

clomipramine; systemic

14.3

307.7

2065

1023

F31

ICD-10 Finland

Bipolar affective disorder

11.2

307.7

1481

931

N06AX12

ATC

bupropion; oral

5.3

307.7

8070

11667

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

307.7

5813

15586

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.8

307.7

1472

1331

N05AC01

ATC

periciazine; systemic

15.3

307.7

461

209

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

307.7

7482

30771

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

10510

43127

N05AX13

ATC

paliperidone; systemic

8.9

307.7

507

393

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

17040

65616

IHZ04, ,

SPAT

4.9

307.7

867

1240

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

7.4

307.7

5254

5284

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

307.7

31531

180359

N06AX26

ATC

vortioxetine; oral

4.6

307.7

7580

12379

F21

ICD-10 Finland

Schizotypal disorder

10.3

307.7

594

400

J01DB01

ATC

cefalexin; oral

1.6

307.7

49939

305566

F33

ICD-10 Finland

Recurrent depressive disorder

4.6

307.7

1924

2970

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.3

307.7

2855

3242

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

14.6

307.7

686

327

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

24812

126631

N06AB06

ATC

sertraline; oral

6.4

307.7

14075

18732

N05AF01

ATC

flupentixol; systemic

13.5

307.7

1749

915

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

307.7

9593

41295

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

12.5

307.7

702

390

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.7

307.7

1339

2012

F41.00

ICD-10 Finland

Moderate panic disorder

10.5

307.7

1901

1280

S06.0

ICD-10 Finland

Concussion

2.0

307.7

6615

23787

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.4

307.7

9491

16666

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

307.7

5436

18395

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.0

307.7

817

711

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

14.6

307.7

544

259

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

307.7

1364

2775

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

9.8

307.7

625

443

R06.0

ICD-10 Finland

Dyspnoea

1.8

307.7

16020

67754

P06

ICPC

Sleep disturbance

2.4

307.7

8324

25767

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

13.5

307.7

666

342

A02BA04

ATC

nizatidine; systemic

2.4

307.7

4510

13561

F20.9

ICD-10 Finland

Schizophrenia, unspecified

12.4

307.7

2532

1456

U04

ICPC

Incontinence urine

2.4

307.7

2770

8270

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

11.4

307.7

2358

1478

ZXY60

NOMESCO Finland

2-person team, nurses

10.0

307.7

543

377

P15

ICPC

Chronic alcohol abuse

5.4

307.7

2731

3581

N05CD02

ATC

nitrazepam; oral

9.5

307.7

1632

1215

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

17723

74763

F60.7

ICD-10 Finland

Dependent personality disorder

13.9

307.7

425

211

P03

ICPC

Feeling depressed

2.9

307.7

8099

20730

F51.0

ICD-10 Finland

Nonorganic insomnia

3.0

307.7

13455

35797

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

307.7

5241

19276

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.6

307.7

2909

4517

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

14832

59436

IHZ05, ,

SPAT

2.7

307.7

2446

6312

M03BX02

ATC

tizanidine; oral

1.5

307.7

36676

206670

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

9.4

307.7

6537

5267

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

7.2

307.7

581

563

N05AF03

ATC

chlorprothixene; systemic

20.0

307.7

4019

1471

N03AF01

ATC

carbamazepine; oral, rectal

3.8

307.7

3928

7469

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

18.9

307.7

859

316

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.7

307.7

1402

2646

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

14.5

307.7

1356

656

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

14.2

307.7

1352

670

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

307.7

5904

22778

N06BA04

ATC

methylphenidate; oral

3.2

307.7

2220

4944

UJF32

NOMESCO Finland

Coloscopy

1.6

307.7

14111

66708

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

17.6

307.7

354

139

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

307.7

2600

6845

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

307.7

5146

19032

OAB43, ,

SPAT

0.6

307.7

8732

92711

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.6

307.7

1737

1602

F61

ICD-10 Finland

Mixed and other personality disorders

12.4

307.7

517

290

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

18.5

307.7

690

260

N30.0

ICD-10 Finland

Acute cystitis

1.7

307.7

9202

38939

A03FA02

ATC

cisapride; oral, rectal

2.4

307.7

4585

13618

N06AX21

ATC

duloxetine; oral

4.3

307.7

11632

21443

M79.7

ICD-10 Finland

Fibromyalgia

2.9

307.7

2207

5382

C10AA01

ATC

simvastatin; oral

1.4

307.7

20639

109152

K59.0

ICD-10 Finland

Constipation

2.6

307.7

3579

9654

N05AC02

ATC

thioridazine; oral

8.7

307.7

2000

1624

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

307.7

26728

130071

A02BX02

ATC

sucralfate; oral

2.6

307.7

2271

6033

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

25367

116571

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

20.3

307.7

612

209

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

307.7

6920

27790

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

6696

26945

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

307.7

5413

18006

SPAT1307

SPAT

Psychosocial counselling and guidance

2.7

307.7

4462

11997

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

307.7

3643

11161

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

307.7

7379

31069

N05CD08

ATC

midazolam; nasal, systemic

7.0

307.7

2043

2058

F60.9

ICD-10 Finland

Personality disorder, unspecified

11.0

307.7

1594

1018

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

7.2

307.7

2660

2629

N03AX12

ATC

[U] gabapentin; oral

2.4

307.7

11307

35994

N02BF02

ATC

pregabalin; oral

3.5

307.7

4585

9523

N06AX18

ATC

reboxetine; oral

10.3

307.7

1118

757

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

8.3

307.7

1215

1024

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

307.7

17254

86575

A04

ICPC

Weakness/tiredness general

1.9

307.7

9109

34575

N05AA02

ATC

levomepromazine; systemic

17.1

307.7

6204

2747

P74

ICPC

Anxiety disorder/anxiety state

6.0

307.7

4666

5730

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.8

307.7

2783

5199

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

307.7

9830

44430

C07AB02

ATC

metoprolol; systemic

1.9

307.7

11621

45618

N05AH02

ATC

clozapine; systemic

16.4

307.7

2569

1120

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

22.9

307.7

695

211

N03AX16

ATC

[U] pregabalin

2.8

307.7

17967

53990

N06AG02

ATC

moclobemide; oral

8.2

307.7

5006

4519

C07AB07

ATC

bisoprolol; oral

1.9

307.7

29334

134094

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

8.1

307.7

1481

1281

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.7

307.7

2855

3063

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.6

307.7

2699

2241

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

10.5

307.7

10639

8217

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

10.7

307.7

468

303

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

8.1

307.7

1618

1408

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

83.5

307.7

278

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

307.7

17144

63561

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

6.3

307.7

650

712

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

12.1

307.7

607

347

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

307.7

2373

5737

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

8.9

307.7

567

440

N05AN01

ATC

lithium; oral

13.9

307.7

3358

1747

N06AX17

ATC

milnacipran; oral

8.0

307.7

995

869

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

307.7

6214

23667

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

307.7

12446

59537

R42

ICD-10 Finland

Dizziness and giddiness

1.8

307.7

13553

56718

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.6

307.7

1459

2798

J01DA01

ATC

[U] cefalexin

1.5

307.7

36523

207122

A02BC01

ATC

omeprazole; systemic

2.0

307.7

17551

71506

R52.2

ICD-10 Finland

Other chronic pain

3.0

307.7

2361

5542

N06AX16

ATC

venlafaxine; oral

6.4

307.7

17883

25159

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.4

307.7

1050

1666

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

307.7

15927

73953

N06AA10

ATC

nortriptyline; systemic

3.7

307.7

1414

2687

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

11.5

307.7

876

531

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

307.7

9297

34377

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

307.7

9248

17661

SPAT1234

SPAT

Support of social functional capacity

3.2

307.7

3494

7796

N05BA02

ATC

chlordiazepoxide; systemic

26.2

307.7

3483

966

ZY000

NOMESCO Finland

Hospital inpatient

9.9

307.7

1416

1006

R06AE07

ATC

cetirizine; oral

1.5

307.7

25781

136584

SPAT1216

SPAT

Assessment of functional ability

1.8

307.7

8342

33212

ZXY49

NOMESCO Finland

Other health care provider

13.7

307.7

552

279

N05BA09

ATC

clobazam; oral

43.2

307.7

910

147

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

12.5

307.7

1010

566

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

27181

148734

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

307.7

23901

126302

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

10.9

307.7

4610

3109

N06AA09

ATC

amitriptyline; systemic

4.1

307.7

8408

15537

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.4

307.7

2704

4327

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

13.7

307.7

2381

1237

J01CA08

ATC

pivmecillinam; oral

1.5

307.7

22736

116760

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.8

307.7

2287

5700

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

42801

222058

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

10.0

307.7

890

619

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.0

307.7

1689

1997

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

12.4

307.7

2486

1433

N05AX08

ATC

risperidone; systemic

7.5

307.7

10383

11052

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.3

307.7

2545

3398

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.5

307.7

2298

3612

E0000UV, ,

ATC

1.5

307.7

23919

126292

F32.1

ICD-10 Finland

Moderate depressive episode

3.1

307.7

4659

10953

A10BA02

ATC

metformin; oral

1.5

307.7

14451

72182

R52.9

ICD-10 Finland

Pain, unspecified

1.9

307.7

5604

21230

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

10254

35452

A06AD11

ATC

lactulose; oral

3.0

307.7

11019

28948

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

12.7

307.7

1094

602

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.6

307.7

645

424

ZYC01

NOMESCO Finland

Remote contact by phone

2.6

307.7

3979

10829

N07BB01

ATC

disulfiram; oral

6.9

307.7

4950

5261

V03AA01, ,

ATC

8.5

307.7

1535

1277

P16

ICPC

Acute alcohol abuse

5.5

307.7

1398

1774

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

16.1

307.7

654

283

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

307.7

4600

16450

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.3

307.7

2779

3133

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

18362

82233

Z71.8

ICD-10 Finland

Other specified counselling

1.5

307.7

17635

88593

P18

ICPC

Medication abuse

21.2

307.7

802

263

P01

ICPC

Feeling anxious/nervous/tense

3.2

307.7

10663

25759

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

307.7

5424

21083

IEY01

NOMESCO Finland

Psychoeducation, individual

7.8

307.7

707

630

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

19433

99833

IGY99

NOMESCO Finland

Other psychiatric treatment contact

7.2

307.7

2026

1987

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.6

307.7

11967

17330

N06AB08

ATC

fluvoxamine; oral

8.8

307.7

2937

2399

F61.0

ICD-10 Finland

Mixed personality disorders

11.2

307.7

2112

1339

SPAT1265

SPAT

Breathalyser

6.1

307.7

795

909

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

13474

58244

N06AX22

ATC

agomelatine; oral

7.3

307.7

2538

2487

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

4.6

307.7

1177

1780

J02AC01

ATC

fluconazole; systemic

1.6

307.7

23114

116027

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

9.4

307.7

2449

1852

F40.1

ICD-10 Finland

Social phobias

6.0

307.7

2410

2869

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.8

307.7

1697

1360

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

307.7

8866

35581

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

22.7

307.7

354

108

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

26819

135097

A03CA02

ATC

clidinium and psycholeptics; oral

3.6

307.7

4203

8542

F22.0

ICD-10 Finland

Delusional disorder

6.3

307.7

1235

1372

P98

ICPC

Psychosis NOS/other

8.4

307.7

622

513

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

307.7

5528

19433

N03AE01

ATC

clonazepam; systemic

7.2

307.7

6558

6882

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.2

307.7

8458

15344

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.0

307.7

3450

8264

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

307.7

3639

10803

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

29.1

307.7

404

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

11.5

307.7

441

266

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.7

307.7

2331

1708

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

29.9

307.7

504

117

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

10.8

307.7

845

545

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

12.5

307.7

1583

892

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

9.9

307.7

797

559

N05CD07

ATC

temazepam; oral

7.8

307.7

14662

16134

M79.6

ICD-10 Finland

Pain in limb

1.5

307.7

23817

123479

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

23.8

307.7

532

155

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

307.7

6894

27507

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

36.4

307.7

602

115

N05CF02

ATC

zolpidem; oral

3.9

307.7

16494

36366

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.7

307.7

2442

4697

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

21278

104551

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

307.7

2897

6008

F60.8

ICD-10 Finland

Other specific personality disorders

8.9

307.7

654

509

H02AB06

ATC

prednisolone; systemic

1.5

307.7

27583

145429

R11

ICD-10 Finland

Nausea and vomiting

2.3

307.7

5587

17441

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

307.7

1882

4073

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

6.7

307.7

8309

9539

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

307.7

10015

45305

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

15754

76323

N05CF01

ATC

zopiclone; oral

5.0

307.7

32057

74394

F29

ICD-10 Finland

Unspecified nonorganic psychosis

7.9

307.7

4319

3977

F34.1

ICD-10 Finland

Dysthymia

6.6

307.7

3923

4342

SPAT1243

SPAT

Psychiatric/psychological examination

3.9

307.7

2129

3867

F20.0

ICD-10 Finland

Paranoid schizophrenia

13.1

307.7

729

387

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

28.2

307.7

649

160

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

18397

84834

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

307.7

9209

32002

F41.01

ICD-10 Finland

Severe panic disorder

16.0

307.7

701

304

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

16318

62637

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

307.7

3790

8276

SPAT1263

SPAT

Sampling

1.4

307.7

23753

128337

188

Kela drug reimbursment

Psychosis requiring demanding treatment

19.0

307.7

1231

455

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

11.2

307.7

918

574

C03CA01

ATC

furosemide; systemic

1.9

307.7

17253

71818

SPAT1240

SPAT

Therapeutic discussion

3.1

307.7

9043

22238

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

6.6

307.7

6808

7814

N06AB04

ATC

citalopram; systemic

6.8

307.7

25665

39904

SPAT1229

SPAT

Assessment of need for aid

2.1

307.7

4197

13970

SPAT1254

SPAT

Administration of medicine

2.1

307.7

9173

33207

N05AE05

ATC

lurasidone; oral

16.7

307.7

496

206

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

307.7

8097

31704

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

33.4

307.7

314

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

307.7

13455

63574

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

15.9

307.7

1977

882

N06AX03

ATC

mianserin; oral

9.4

307.7

5904

4699

M02AA07

ATC

piroxicam; topical

1.5

307.7

19501

98094

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

18.9

307.7

390

143

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

307.7

8536

34804

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

17403

85104

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

10.9

307.7

687

439

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

12.1

307.7

629

362

N05AL01

ATC

sulpiride; systemic

15.1

307.7

1723

807

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

307.7

13555

63910

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.9

307.7

2904

7191

F32.8

ICD-10 Finland

Other depressive episodes

4.7

307.7

1257

1883

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.9

307.7

1761

2526

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015736) pH of Urine

24747

136954

1.40

322.23

3.9

3.1

5.90

5.87

0.63

1492

11465

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

51851

326279

1.51

320.20

17.2

11.8

83.77

83.75

ml/min/173m2

0.05

43768

267924

(3003396) Base excess in Arterial blood by calculation

7971

35026

1.65

317.20

7.3

1.27

0.98

mmol/l

8.09

6514

27658

(3002032) Base excess in Venous blood by calculation

6731

28284

1.71

316.77

3.9

4.0

1.99

1.80

mmol/l

3.80

5738

24035

(3027801) Oxygen [Partial pressure] in Arterial blood

7961

35001

1.65

316.04

7.2

7.3

11.77

12.66

kpa

41.96

7613

33331

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7962

35025

1.65

315.33

7.2

7.3

5.18

5.06

kpa

20.56

7616

33365

(3012544) pH of Venous blood

6923

29403

1.70

313.12

3.8

4.0

7.38

0.17

219

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6730

28391

1.71

311.93

3.9

4.0

5.92

5.81

kpa

13.56

6467

27602

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

930

1510

4.29

311.92

2.4

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8321

37178

1.62

309.29

2.8

2.7

7.59

8.58

umol/l

3.74

6851

32399

(3003181) Sodium [Moles/volume] in Urine

1776

4476

2.78

308.01

1.4

57.94

64.71

mmol/l

8.16

1328

3600

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1234

2289

3.76

307.65

1.8

1.3

1.45

1.36

promille

1.05

909

1805

(3026008) Bacteria identified in Urine by Culture

20816

97553

1.70

307.65

3.6

2.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

47676

257390

2.10

307.65

8.7

7.1

78.59

77.18

u/l

8.22

44883

243006

(3002582) Erythrocytes [#/volume] in Urine

19940

99006

1.56

307.65

3.6

3.1

63.90

94.11

e6/l

3.07

15542

75395

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4863

18139

1.92

307.65

1.6

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23435

110125

1.74

307.65

3.8

3.1

34.08

33.07

u/l

0.63

21964

104671

(3019225) pH of Specimen

7660

29606

1.89

307.65

4.4

4.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4689

17376

1.93

307.65

1.8

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25203

119961

1.74

307.65

4.4

3.3

66.69

61.62

ng/l

0.16

17245

76664

(3009466) Valproate [Moles/volume] in Serum or Plasma

3328

2767

8.68

307.65

5.8

4.3

376.47

358.59

umol/l

5.74

2933

2350

(36304419) Bacteria [Presence] in Urine

17950

88302

1.56

307.65

3.4

3.0

—

(3018418) pH of Serum or Plasma

20689

92858

1.79

307.65

4.2

4.1

7.40

0.07

4344

17408

(3014111) Lactate [Moles/volume] in Serum or Plasma

6738

26868

1.81

307.65

6.6

7.1

1.39

1.35

mmol/l

1.67

6530

26203

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

13295

55829

1.81

307.65

3.1

2.9

2.45

mmol/l

1.01

11531

48694

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10180

47018

1.58

307.65

2.4

2.5

2.37

2.35

g/l

4.83

9180

43602

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12467

50162

1.88

307.65

3.4

0.81

0.82

mmol/l

10.84

11530

47058

(3011288) Drugs identified in Urine by Screen method

4188

8751

3.46

307.65

5.5

2.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

24475

105331

1.97

307.65

3.3

2.35

mmol/l

0.03

21278

93350

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8242

28632

2.13

307.65

2.2

368.39

376.88

nmol/l

3.00

7467

26517

(3013707) Erythrocyte sedimentation rate by Westergren method

43932

252539

1.64

307.65

4.5

3.9

12.45

11.47

mm/h

36.17

40314

234983

(3013512) EKG study

18762

89939

1.62

307.65

4.3

3.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8185

34131

1.75

307.65

1.9

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

3563

4698

5.47

307.65

4.4

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

4711

14251

2.38

307.65

4.1

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

30473

159066

1.61

307.65

7.0

5.9

2.72

2.87

25.43

28304

149294

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

880

1010

6.07

307.65

2.3

1.8

147.10

126.38

umol/l

0.75

435

517

(3024561) Albumin [Mass/volume] in Serum or Plasma

29376

138613

1.85

307.65

4.9

4.8

35.49

35.73

g/l

9.81

27047

128871

(3002030) Lymphocytes/100 leukocytes in Blood

31150

165428

1.58

307.65

7.1

5.9

27.67

28.20

13.93

29041

155957

(3016879) Cocaine [Presence] in Urine

4601

13083

2.53

307.65

4.1

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7354

29724

1.79

307.65

2.8

2.4

37.76

46.58

u/l

1.48

6221

25545

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

35052

169376

1.95

307.65

6.7

5.8

10.26

11.51

umol/l

59.80

32921

160588

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

955

540

12.34

307.65

2.5

2.3

152.57

146.57

nmol/l

0.45

835

463

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1936

920

14.91

307.65

18.3

19.1

1983.28

3735.49

nmol/l

0.44

1861

878

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1849

862

15.17

307.65

13.4

13.3

867.09

1897.65

nmol/l

0.43

1786

832

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12290

49687

1.87

307.65

2.0

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7271

28730

1.84

307.65

2.4

2.2

0.22

g/l

0.06

6663

26784

(3013826) Glucose [Moles/volume] in Serum or Plasma

37280

194240

1.78

307.65

5.6

4.5

6.65

6.68

mmol/l

1.74

35284

179899

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5876

22509

1.88

307.65

1.7

1.6

—

(3009343) pH of Capillary blood

5271

18543

2.04

307.65

3.9

3.4

7.42

0.13

776

2394

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47025

265210

1.85

307.65

5.0

3.8

14.60

14.71

pmol/l

15.70

42766

242862

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15293

66075

1.78

307.65

1.7

1.6

26065308.75

37424826.64

pmol/l

1.61

12396

55389

(3009508) Creatinine [Moles/volume] in Urine

19797

100573

1.52

307.65

3.6

3.2

7.20

7.99

mmol/l

6.83

16433

85863

(3036180) Methadone [Presence] in Urine

1115

1137

6.85

307.65

2.8

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

30660

162962

1.57

307.65

6.9

5.7

57.57

57.10

9.56

28535

153564

(3000850) Epithelial cells [#/volume] in Urine

14549

68086

1.61

307.65

2.8

2.5

6.83

5.53

e6/l

10.54

13060

60858

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17768

85320

1.60

307.65

3.1

2.9

1288.54

1410.92

ng/l

2.88

14787

72572

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

31529

141639

2.06

307.65

6.3

5.9

1.21

mmol/l

1.80

28705

129561

(3013650) Neutrophils [#/volume] in Blood by Automated count

36905

195183

1.72

307.65

12.3

8.3

4.25

4.09

e9/l

28.63

32475

170714

(3023183) Ammonium ion [Moles/volume] in Plasma

2269

5870

2.72

307.65

2.8

2.7

33.64

33.94

umol/l

0.19

2056

5297

(3023103) Potassium [Moles/volume] in Serum or Plasma

56616

354121

1.93

307.65

21.9

14.4

3.96

mmol/l

0.30

55173

344348

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5349

18772

2.05

307.65

3.9

3.4

5.22

5.12

kpa

15.90

5066

17734

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

18296

80559

1.79

307.65

2.4

2.2

2.97

2.90

mg/l

2.73

15394

69131

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23371

102249

1.91

307.65

3.0

2.5

55.89

62.76

u/l

5.58

21309

94756

(3023368) Bacteria identified in Blood by Culture

19326

84472

1.83

307.65

4.8

4.1

—

(3018095) Leukocytes [#/volume] in Urine

22932

117178

1.54

307.65

4.2

3.5

94.69

95.40

e6/l

0.04

16579

81526

(40768797) Stomach Pathology biopsy report

9993

43880

1.67

307.65

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

27188

151250

1.41

307.65

11.7

9.0

0.00

e9/l

0.87

22335

124370

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

41079

235489

1.57

307.65

4.3

2.8

54.08

45.31

u/l

52.43

38143

221574

(3019550) Sodium [Moles/volume] in Serum or Plasma

56567

353009

1.94

307.65

21.8

14.2

139.29

139.69

mmol/l

224.83

55204

343979

(3033658) Prothrombin time (PT) actual/Normal

16853

83634

1.53

307.65

4.5

3.8

91.41

90.79

2.38

16311

81549

(3021960) Folate [Moles/volume] in Serum or Plasma

17170

70235

1.94

307.65

1.6

1.5

20.29

20.28

nmol/l

0.05

14790

60722

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5107

17907

2.05

307.65

3.8

3.4

1.79

1.62

mmol/l

2.32

3902

12975

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27727

135568

1.72

307.65

2.5

2.2

76.08

742.41

nmol/l

0.50

24836

123120

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

28151

128966

1.90

307.65

2.2

1.9

97.11

95.90

pmol/l

3.63

14805

68410

(3022217) INR in Platelet poor plasma by Coagulation assay

29787

148249

1.72

307.65

14.6

13.9

1.21

1.25

inr

10.54

9387

43324

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2407

5677

2.99

307.65

1.6

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

10978

51169

1.58

307.65

2.5

12.86

13.79

umol/l

1.67

10018

47878

(3028300) Cannabinoids [Presence] in Urine

4721

14394

2.36

307.65

4.2

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

31155

159107

1.68

307.65

7.2

6.2

—

(3026782) Osmolality of Urine

13978

64414

1.63

307.65

3.1

2.8

503.35

551.43

mosm/kgh2o

104.19

12000

55260

(3024666) Lithium [Moles/volume] in Serum or Plasma

1719

947

12.81

307.65

12.4

11.5

0.62

mmol/l

0.29

1567

885

(3030467) Casts [#/volume] in Urine by Automated count

18360

90290

1.56

307.65

3.5

3.0

0.43

0.40

e6/l

0.71

14205

68133

(3037467) Urinalysis macro (dipstick) panel - Urine

41742

236845

1.62

307.65

5.1

4.0

—

(3042517) Benzodiazepines panel - Urine

496

104

33.07

307.65

3.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4271

10524

2.92

307.65

4.2

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

23342

117269

1.58

307.65

3.6

3.2

0.51

0.23

e6/l

—

(3027008) Opiates [Presence] in Urine

4705

14363

2.35

307.65

4.1

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

28518

153063

1.51

307.65

3.2

2.8

120.96

119.23

ug/l

0.37

25950

143119

(40758558) Short blood count panel - Blood

17062

83481

1.56

307.65

8.6

6.5

—

(3022096) Basophils/100 leukocytes in Blood

29608

153834

1.61

307.65

7.0

5.9

0.66

0.68

10.04

27422

143909

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9813

40346

1.80

307.65

5.4

6.1

1.03

1.04

mmol/l

2.85

9052

37703

(3027944) Amphetamines [Presence] in Urine

4474

14261

2.25

307.65

3.9

1.5

—

(3001604) Monocytes [#/volume] in Blood

32552

169060

1.67

307.65

6.9

5.7

0.59

0.58

e9/l

7.42

28288

147323

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

21644

94831

1.87

307.65

2.5

2.0

243.41

202.03

u/l

3.08

20243

89093

(3019198) Lymphocytes [#/volume] in Blood

33240

174876

1.65

307.65

7.0

5.7

1.95

1.93

e9/l

0.95

29398

155764

(3013115) Eosinophils [#/volume] in Blood

33547

175154

1.67

307.65

7.6

5.8

0.19

e9/l

7.53

29405

154628

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12564

40736

2.40

307.65

2.4

1.6

1.57

1.40

104.86

10916

36349

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8213

33920

1.77

307.65

1.9

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

33901

157395

2.03

307.65

7.0

6.5

1.21

mmol/l

0.13

28434

133978

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

52747

318840

1.82

307.65

6.1

4.4

1.88

2.10

mu/l

3.83

48538

294721

(3006315) Basophils [#/volume] in Blood

32656

169432

1.67

307.65

6.9

5.7

0.04

e9/l

0.22

28331

147520

(3031040) Bacteria [#/volume] in Urine by Automated count

41348

223705

1.78

307.65

5.6

4.1

1929.51

1213.36

e6/l

1.29

602

3086

(3019069) Monocytes/100 leukocytes in Blood

30633

159979

1.61

307.65

7.4

6.1

8.40

8.51

6.40

28509

150388

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14994

73818

1.52

307.65

1.9

1.7

1.16

1.19

mg/l

0.38

11197

56073

(3044889) 12 lead EKG panel

39451

233096

1.44

307.65

4.3

3.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

49980

311470

1.49

307.65

6.4

5.3

39.54

39.34

mmol/mol

4.67

45711

290503

(3019309) Folate [Moles/volume] in Red Blood Cells

15275

54857

2.21

307.65

1.9

1.7

1187.29

1159.34

nmol/l

2.89

11414

41921

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

55139

351571

1.60

307.65

19.5

12.7

22.82

23.29

mg/l

2.57

46350

275204

(3000991) Gas panel - Venous blood

6200

25737

1.73

304.01

7.8

8.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3115

10279

2.14

302.80

2.2

2.4

451.40

553.36

ug/l

1.06

2885

9600

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9453

43762

1.57

302.33

2.5

2.6

21.87

23.11

13.38

8057

37417

(3044640) Blood type and Crossmatch panel - Blood

19841

106731

1.41

298.11

2.6

2.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12422

61337

1.49

294.14

4.2

3.5

245.71

543.13

ng/l

14.10

8929

45756

(3027945) Reticulocytes/100 erythrocytes in Blood

7702

34247

1.62

290.36

2.5

1.82

1.74

8.05

6617

30451

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

52357

331733

1.49

290.11

5.3

4.1

6.01

5.86

mmol/l

103.43

47409

305837

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7244

31755

1.64

288.88

4.2

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

8574

39237

1.58

286.65

1.9

1.7

—

(21494755) Public health laboratory ask at order entry panel

3244

41511

0.51

286.58

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

29427

169738

1.36

284.20

4.3

3.4

0.00

estimate

6.63

6588

33533

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14982

77310

1.44

280.43

1.3

1.37

1.70

u/ml

2.57

3778

21527

(3022313) Gas panel - Capillary blood

3689

13361

1.96

278.55

4.1

3.6

—

(3009261) Glucose [Presence] in Urine by Test strip

29638

171493

1.36

278.09

4.3

3.4

0.00

estimate

1.45

6228

31020

(3021601) Nitrite [Presence] in Urine by Test strip

29364

169707

1.35

277.34

5.6

4.6

0.00

estimate

0.62

6350

31990

(3024354) Oxygen [Partial pressure] in Venous blood

5588

23138

1.73

274.91

3.4

3.3

4.72

4.61

kpa

3.07

5330

22409

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15422

80438

1.42

270.32

2.6

2.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

13161

66763

1.45

267.85

1.5

1.4

2.38

2.37

g/l

0.18

7548

41803

(3042936) Bacteria identified in Isolate by Culture

9674

46178

1.52

266.08

2.2

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4683

18646

1.79

263.16

6.8

7.3

24.98

24.67

mmol/l

6.26

4627

18481

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5948

25358

1.68

262.31

4.3

3.7

1.23

mmol/l

0.88

5112

22215

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3853

14462

1.89

261.27

3.9

4.5

24.26

24.05

mmol/l

3.60

3728

14148

(3016502) Oxygen saturation in Arterial blood

7024

31361

1.61

258.10

7.7

95.10

95.81

14.80

6813

30122

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

913

1694

3.75

257.42

1.8

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

761

1248

4.24

252.06

1.9

1.4

2103305.64

1382584.06

iu/ml

0.79

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3237

11605

1.97

250.94

4.3

3.7

24.91

24.73

mmol/l

2.66

3014

10718

(3029937) Albumin [Presence] in Urine by Test strip

16888

90617

1.38

246.56

4.8

3.7

0.00

estimate

1.54

6160

30689

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5075

21081

1.71

245.44

3.0

3.4

4.38

4.53

pmol/l

18.12

4332

19026

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8262

38854

1.53

241.13

8.2

6.5

—

(3010421) pH of Blood

2434

7991

2.14

238.56

4.4

3.7

7.42

1.79

2200

7311

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2575

8715

2.08

233.30

1.4

277.15

274.86

ug/g

0.17

1449

5041

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11050

55562

1.45

230.73

3.0

2.7

1.50

1.09

e6/l

0.90

6152

31477

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9939

49155

1.46

225.70

2.1

29.79

29.78

0.07

9598

47740

(3048689) Calprotectin [Mass/mass] in Stool

8862

42845

1.49

225.47

2.3

2.4

135.40

132.21

ug/g

0.33

6724

34176

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10393

51888

1.45

224.57

3.2

2.8

3.49

2.87

e6/l

4.97

5518

28000

(3012501) Base excess in Blood by calculation

2156

6929

2.18

222.60

4.5

3.7

2.57

2.46

mmol/l

0.88

1495

4583

(3013290) Carbon dioxide [Partial pressure] in Blood

2156

6931

2.18

222.44

4.5

3.7

5.07

4.98

kpa

5.76

2096

6774

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3401

12905

1.86

221.96

2.2

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

8075

38439

1.51

220.98

4.6

4.2

31.51

32.29

7.55

5599

27307

(3027315) Oxygen [Partial pressure] in Blood

2161

6977

2.17

220.58

4.5

3.8

8.67

8.68

kpa

0.10

2101

6819

(3023520) Reticulocytes [#/volume] in Blood

5700

25135

1.62

218.00

2.5

2.6

71.55

69.25

e9/l

4.34

4251

18963

(1616796) Gas panel - Central venous blood

2119

6837

2.17

216.59

4.0

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3146

11735

1.89

216.26

2.0

1.8

—

(3019060) Gas panel - Arterial blood

4727

19951

1.68

214.27

4.9

4.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6120

27571

1.58

213.92

7.0

7.7

9.07

9.81

mmol/l

12.51

5787

26218

(3019150) Specific gravity of Urine by Refractometry

13872

73468

1.38

213.25

4.8

3.7

1.02

kg/l

0.84

2002

11210

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

321

250

8.88

213.06

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5788

25784

1.60

211.97

2.5

2.2

6.11

7.50

ug/l

4.36

4772

22619

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6331

29115

1.55

201.60

8.2

8.1

122.05

121.78

g/l

0.47

6200

28289

(3008295) Osmolality of Serum or Plasma

1088

2641

2.87

201.49

1.5

277.86

280.27

mosm/kgh2o

2.21

822

2091

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2231

7571

2.07

200.23

3.2

2.9

25.04

24.53

mmol/l

6.59

2182

7396

(3011397) Hemoglobin [Presence] in Urine by Test strip

14477

78362

1.35

190.19

4.1

3.4

—

(40767503) Oxygen content in Capillary blood by calculation

1958

6461

2.12

188.86

2.8

2.4

16.56

16.52

0.11

1029

3319

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3862

15972

1.71

187.74

8.8

9.7

24.44

24.25

mmol/l

2.80

3695

15440

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

258

185

9.63

181.01

7.0

7.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2355

8457

1.95

180.51

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5098

22925

1.58

177.75

3.4

4.0

86.75

91.73

ng/l

2.76

4288

19973

(3012516) Albumin [Mass/volume] in Urine

16638

92742

1.32

176.22

3.2

3.3

436.98

408.17

mg/l

0.30

10250

59967

(3000494) Fungus identified in Specimen by Culture

7769

38287

1.45

175.27

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4392

19192

1.62

172.33

8.9

9.3

1.54

1.35

19.91

4370

19054

(3017181) Myelocytes/100 leukocytes in Blood

5911

27670

1.52

171.87

4.3

4.1

0.93

0.95

0.30

2230

8961

(3020630) Protein [Mass/volume] in Serum or Plasma

5399

24816

1.54

170.63

2.4

2.5

66.23

66.60

g/l

2.79

4817

22668

(3014007) Fractional oxyhemoglobin in Arterial blood

4391

19239

1.61

170.35

9.0

9.4

93.31

94.02

10.49

4375

19167

(3020682) Albumin/Creatinine [Ratio] in Urine

17361

97700

1.31

170.31

3.8

3.9

9.93

9.35

mg/mmol

0.63

10413

62842

(3017143) Hepatitis C virus Ab [Presence] in Serum

8545

43077

1.42

170.04

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1994

6906

2.02

169.05

3.4

3.1

8.26

8.31

kpa

0.75

1955

6736

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4367

19187

1.61

167.39

8.9

9.4

0.68

0.67

0.06

4349

19060

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7380

36332

1.45

166.72

3.8

4.2

234.51

243.49

u/l

5.64

6874

34445

(3028271) Lactate [Moles/volume] in Capillary blood

1517

4762

2.22

165.36

2.1

1.8

1.74

1.75

mmol/l

0.17

1488

4643

(40761536) Microorganisms panel - Urine sediment

6056

28988

1.48

157.29

4.7

3.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5398

25233

1.52

157.19

4.0

3.9

0.65

0.68

0.44

1951

7721

(3021440) Promyelocytes/100 leukocytes in Blood

5598

26376

1.51

157.00

4.3

4.1

0.11

0.12

0.34

1929

7712

(3020891) Body temperature

2946

11958

1.73

152.27

5.3

4.8

—

(3037522) Nuclear Ab [Titer] in Serum

9087

47170

1.38

150.61

1.4

1.3

490.78

549.93

titre

2.34

1815

9491

(3007463) Buprenorphine [Presence] in Urine

152

18.72

149.08

9.4

3.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

56526

372033

1.42

148.98

21.5

14.5

76.14

76.62

umol/l

2.44

56517

371853

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3400

36443

0.62

147.86

1.8

1.7

—

(3025941) Bacteria identified in Stool by Culture

4389

19860

1.56

147.72

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

56734

373753

1.42

147.27

13.2

9.4

27.23

26.47

u/l

7.71

54729

361426

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3344

14180

1.66

146.95

3.2

2.9

1.52

1.24

26.28

3330

14105

(3004588) Protein electrophoresis panel - Serum or Plasma

4428

20109

1.55

146.63

2.2

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1826

22964

0.53

146.19

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

1631

5536

2.05

145.82

2.9

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22411

132198

1.26

144.76

4.6

3.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1342

4251

2.20

143.02

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2869

11826

1.70

140.05

2.1

2.0

2.01

2.31

ug/l

0.68

2483

10459

(3018405) Lactate [Moles/volume] in Arterial blood

2613

10497

1.74

139.82

4.3

4.2

1.38

mmol/l

0.02

2581

10298

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1827

6561

1.94

139.60

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5238

24908

1.49

139.59

2.6

2.7

10.32

10.63

g/l

5.73

4723

22846

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1827

6565

1.94

139.35

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2130

8062

1.85

138.83

1.3

487.91

546.76

mg/l

2.66

2016

7695

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3246

13910

1.64

136.65

3.2

2.9

0.65

0.66

0.79

3236

13855

(3025159) Blasts/100 leukocytes in Blood

5251

25111

1.48

135.88

4.4

4.2

0.16

0.35

1.91

1591

6535

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4218

19313

1.54

134.16

7.7

7.0

24.97

24.48

mmol/l

13.41

4065

18329

(3022806) Fractional oxyhemoglobin in Capillary blood

1232

3891

2.20

132.21

2.1

1.7

89.81

89.91

0.25

1213

3831

(4200892) Spirometry reversibility

4875

23182

1.48

129.42

1.5

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26890

163312

1.23

127.88

2.8

2.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

486

948

3.55

127.80

3.2

2.7

29.78

27.96

umol/l

1.95

357

726

(3052851) Hemolysis interference index of Serum or Plasma

2381

9606

1.73

125.28

3.2

3.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1886

7093

1.86

125.28

1.2

1.3

3.81

3.72

mmol/l

2.10

1765

6659

(3022145) Colonoscopy Study observation

7253

37297

1.38

125.15

1.3

1.4

—

(40761535) Cells panel - Urine sediment

5372

26241

1.45

124.00

3.7

3.4

—

(40768804) Tissue Pathology biopsy report

23162

139031

1.23

120.78

2.2

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1878

7151

1.83

119.91

2.3

2.1

131.19

130.50

g/l

0.50

1397

5235

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8149

43046

1.35

118.02

2.3

2.0

—

(3016038) Potassium [Moles/volume] in Urine

674

1690

2.76

117.73

1.2

30.38

35.58

mmol/l

6.80

553

1474

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1859

7131

1.82

115.88

1.4

26.94

31.21

e6/l

0.20

1428

5523

(3028026) IgM [Mass/volume] in Serum or Plasma

4103

19265

1.50

115.34

1.9

1.36

1.30

g/l

0.66

3720

17614

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1858

7140

1.81

115.14

1.4

1.5

2915.92

1806.97

e6/l

0.24

1522

5793

(3021387) Prolactin [Units/volume] in Serum or Plasma

3089

13649

1.59

114.25

1.7

1.6

406.20

290.30

mu/l

13.90

2721

12363

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10763

59417

1.30

113.65

1.3

29.80

35.18

iu/ml

2.08

3004

19369

(3044290) Cell count panel - Cerebral spinal fluid

1760

6695

1.83

112.68

1.3

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

2218

9089

1.70

110.17

4.6

4.5

3.84

3.89

mmol/l

3.82

2207

9002

(3004119) Hemoglobin [Mass/volume] in Venous blood

3969

18702

1.49

109.46

3.6

3.4

129.37

129.40

g/l

0.03

3869

18284

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1779

6930

1.79

105.35

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1471

5418

1.89

104.07

1.4

1.3

24.53

25.44

u/l

0.45

1140

4546

(1761868) Lipid panel - Serum or Plasma

16449

131579

0.81

103.68

3.0

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1835

7260

1.76

103.10

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2292

9644

1.66

103.03

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6133

31631

1.37

102.42

3.6

4.0

21.94

25.25

ug/l

0.37

4937

25234

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8783

47845

1.31

101.07

2.4

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2301

9744

1.65

100.88

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2304

9770

1.65

100.47

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

108

16.18

99.94

1.5

1.2

421.33

641.41

nmol/l

1.58

108

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3090

14097

1.53

98.99

1.6

1.8

1.60

1.50

g/l

6.04

2576

12099

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2285

24554

0.63

98.18

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

5420

27598

1.38

97.63

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

1120

3868

2.01

95.42

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

2159

9146

1.65

94.45

1.2

91.08

126.58

titre

2.03

203

827

(3024928) Oxygen saturation in Venous blood

1628

6390

1.77

93.93

3.0

3.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1376

5146

1.86

92.86

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1131

3967

1.98

92.29

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1239

15320

0.55

92.26

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1152

4071

1.96

92.03

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1120

3922

1.98

91.81

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1743

7026

1.73

91.69

1.7

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1120

3925

1.98

91.62

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

14783

86542

1.23

91.46

1.7

1.6

1.54

1.36

mmol/l

67.34

12232

73481

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1120

3930

1.98

91.29

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1126

3979

1.96

89.97

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2175

9359

1.62

89.37

1.9

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9976

56020

1.27

89.23

1.3

9.10

11.72

u/ml

3.29

3531

22390

(3017732) Neutrophils [#/volume] in Blood

4668

23542

1.39

88.62

3.7

2.5

5.13

4.87

e9/l

0.52

3547

19412

(3026493) Urate [Moles/volume] in Serum or Plasma

15064

88613

1.22

88.34

2.6

4012.93

4101.41

umol/l

0.10

12783

78632

(3016650) Hepatitis A virus Ab [Presence] in Serum

1434

5520

1.81

88.25

1.1

—

(40761511) CBC panel - Blood by Automated count

55436

368277

1.28

86.22

18.4

11.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1860

7797

1.66

84.65

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

477

1187

2.78

84.63

2.6

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1403

5460

1.79

83.27

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3136

14882

1.47

82.82

3.7

3.4

25.35

25.20

mmol/l

1.50

3044

14425

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

483

1226

2.72

82.62

2.8

2.3

57.23

49.83

umol/l

4.79

402

1063

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2923

13701

1.49

82.06

4.2

3.9

51.38

47.86

11.40

2878

13563

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1045

3722

1.95

81.64

2.2

2.0

24.49

26.65

mg/l

0.56

269

1012

(3009214) Lutropin [Units/volume] in Serum or Plasma

2412

10888

1.55

80.75

1.4

10.30

9.67

u/l

1.31

1895

9014

(3034770) Mitochondria Ab [Titer] in Serum

2073

9040

1.60

80.56

1.2

847.11

940.91

titre

0.22

263

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3705

18286

1.42

79.33

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

876

11481

0.52

79.11

1.5

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1170

4380

1.85

78.71

1.3

0.19

0.25

nmol/l

0.98

252

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1170

4396

1.85

77.82

1.3

1.68

1.18

nmol/l

0.25

1125

4233

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4754

24554

1.36

77.48

1.2

112.38

146.28

iu/ml

7.32

1561

9498

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1048

12935

0.55

77.30

1.4

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4933

25645

1.35

77.06

3.0

2.8

190.97

204.58

ng/l

1.23

4443

23270

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2269

10230

1.55

76.33

2.7

2.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2548

11785

1.51

76.19

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

786

10514

0.51

75.71

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1070

3966

1.87

74.25

1.3

—

(3014271) Vancomycin [Susceptibility]

501

1373

2.52

73.84

3.1

2.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3364

16615

1.42

71.52

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

859

2995

1.99

71.34

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4488

23283

1.35

70.80

2.4

2.3

23.42

22.56

au/ml

0.20

309

1912

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

616

8717

0.48

70.31

1.3

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

770

10117

0.52

70.02

1.4

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4141

21253

1.36

69.97

1.3

53.41

51.61

au/ml

0.16

165

1090

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2645

12552

1.47

69.61

1.6

1.7

—

(3005033) Fetal Nuchal fold Thickness US

748

9878

0.52

69.13

1.3

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4902

25856

1.33

69.12

2.6

2.1

12.14

12.31

nmol/l

0.71

4211

23451

(3047352) Trisomy 18 risk [Likelihood] in Fetus

750

9895

0.52

69.10

1.3

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

949

3465

1.90

68.96

1.3

1.2

21.60

30.24

nmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

15672

94298

1.19

68.85

3.9

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1254

4998

1.74

68.61

2.8

3.3

1.38

1.55

0.91

1120

4434

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1001

12104

0.56

68.50

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1004

12130

0.56

68.49

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1005

12122

0.56

68.14

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

2355

10968

1.50

68.01

3.1

3.2

0.29

0.33

g/l

1.29

990

4949

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1000

12065

0.56

67.87

1.3

1.4

—

(3003338) MCHC [Mass/volume]

42661

308434

0.85

67.76

26.5

15.8

332.01

332.77

g/l

54.97

42328

305980

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

693

2279

2.10

67.35

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2313

10768

1.50

66.92

2.1

2.3

2.94

2.93

g/l

0.25

2009

9682

(3042631) Mycobacterium sp identified in Specimen

1048

3991

1.82

66.81

2.7

2.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

734

2479

2.05

66.53

1.3

1.2

1.97

2.10

mmol/l

2.74

682

2293

(3026389) Candida sp identified in Specimen by Organism specific culture

1207

4807

1.74

66.22

1.4

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1065

4091

1.80

66.01

1.6

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

12470

73893

1.20

64.05

2.1

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1382

5775

1.66

63.61

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1302

5358

1.69

63.49

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2416

11487

1.47

62.89

2.1

2.2

7.43

7.36

g/l

1.14

2109

10397

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1016

3907

1.80

62.77

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2412

11475

1.46

62.58

2.1

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2098

9712

1.50

62.33

2.2

2.4

0.70

0.89

g/l

1.63

1749

8387

(3040151) Glucose [Moles/volume] in Capillary blood

937

3526

1.84

62.07

8.7

7.9

7.26

7.36

mmol/l

0.22

788

2862

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2405

11456

1.46

62.00

2.1

2.2

3.71

3.72

g/l

0.16

2104

10374

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1140

4558

1.73

61.70

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

762

2698

1.96

60.65

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4291

22614

1.33

60.52

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2254

10709

1.46

58.85

2.1

2.2

9.82

10.26

g/l

4.82

1938

9557

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3357

17119

1.37

58.75

10.0

9.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2739

13552

1.41

57.40

1.3

1.2

0.59

0.88

u/ml

1.02

228

1173

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1915

8863

1.50

56.92

2.0

2.2

37.81

g/l

0.01

1605

7755

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1605

7152

1.56

56.78

2.1

1.8

192.07

195.65

pmol/l

0.60

1494

6827

(3016018) Differential panel - Cerebral spinal fluid

919

3536

1.80

56.71

1.4

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2844

14204

1.40

56.43

1.4

1.6

14.58

14.56

u/ml

0.00

409

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

719

2567

1.94

55.91

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

719

2567

1.94

55.91

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

719

2567

1.94

55.91

1.6

—

(4035726) Immunohistochemistry procedure

5148

28142

1.28

55.13

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

866

3305

1.81

54.89

3.1

3.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1042

4202

1.72

54.75

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

385

1081

2.46

54.13

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

803

3015

1.84

53.64

2.9

3.3

56.13

57.14

0.65

689

2533

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

10.96

53.38

1.7

1.3

265.43

197.27

nmol/l

0.52

(3023419) Bacteria identified in Sputum by Culture

1079

4424

1.69

53.38

2.6

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2293

11135

1.43

53.29

1.6

265.68

283.95

titre

0.11

467

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4602

39816

0.78

52.98

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2168

10443

1.44

52.63

1.9

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1971

9323

1.47

52.60

3.3

58.30

66.94

mg/l

0.40

1551

7568

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

871

3378

1.79

52.39

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

538

1770

2.10

52.36

1.0

40.60

41.94

ng/l

0.26

380

1233

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

841

3237

1.80

51.87

1.6

1.7

—

(3019977) pH of Arterial blood

501

1609

2.15

51.84

3.2

2.3

7.42

0.06

179

554

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

533

1758

2.10

51.55

1.0

289.10

342.60

ng/l

1.52

388

1242

(3011985) Renin [Units/volume] in Plasma

1055

4343

1.68

51.43

1.5

1.6

59.49

66.03

mu/l

0.50

920

3913

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

535

1769

2.09

51.41

1.0

780.85

736.86

ng/l

1.25

369

1213

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

147

233

4.35

51.15

1.2

50.67

46.05

mg/l

0.46

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1221

5232

1.62

50.95

3.4

3.0

0.81

0.80

nmol/l

0.23

902

4060

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

383

5719

0.46

50.92

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1911

9046

1.47

50.80

3.2

4.63

4.07

ratio

0.07

166

699

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1840

8645

1.48

50.79

2.1

2.3

0.02

0.03

g/l

0.87

1641

7927

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

378

1085

2.41

50.75

1.4

14.14

14.98

pmol/l

1.88

293

938

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1958

9319

1.46

50.61

3.3

39.01

43.44

mg/l

0.56

1536

7575

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

8.40

50.13

1.9

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

754

2840

1.84

49.90

2.8

2.7

—

(3023410) Appearance of Cerebral spinal fluid

840

3276

1.77

49.61

1.5

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1001

4105

1.69

49.51

6.5

6.2

11.29

11.46

mg/l

0.51

910

3779

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

52355

349292

1.18

49.40

5.2

4.5

2.72

2.79

mmol/l

60.85

47541

325965

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1705

7978

1.48

48.03

2.1

2.3

0.00

g/l

0.03

1511

7286

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2721

13857

1.37

47.84

1.1

8.27

9.24

u/ml

0.05

219

(3013005) Retinol [Moles/volume] in Serum or Plasma

413

1274

2.24

47.18

1.7

2.04

1.96

umol/l

0.93

382

1199

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1146

4930

1.61

47.09

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

550

1905

2.00

46.72

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

704

2653

1.84

46.55

1.7

2.1

19.06

18.69

nmol/l

0.45

641

2537

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1774

8420

1.46

46.51

1.8

1.9

14.58

18.77

iu/l

0.16

595

3158

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

540

1872

1.99

45.77

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1004

4208

1.65

45.77

1.9

1.8

2780.00

4284.60

titre

0.74

174

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

393

1203

2.26

45.74

1.6

1.7

29.21

29.14

umol/l

0.04

381

1157

(3019230) Fractional oxyhemoglobin in Venous blood

1206

5291

1.58

45.67

3.1

3.2

63.32

65.04

1.87

1196

5271

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5018

27946

1.26

45.66

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

437

1401

2.15

45.50

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

437

1402

2.15

45.42

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2102

10350

1.41

45.18

3.1

3.2

0.36

0.34

u/ml

0.83

1207

5856

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

759

2964

1.77

44.68

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1667

7880

1.47

44.62

2.1

2.3

0.00

g/l

-0.00

1503

7269

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

401

1252

2.21

44.55

1.3

1.4

73.40

72.84

0.34

376

1196

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1160

5073

1.58

44.54

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1160

5074

1.58

44.50

1.6

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

10.69

44.38

1.7

1.3

194.79

419.44

nmol/l

0.93

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1491

6902

1.50

44.28

1.5

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

1504

6981

1.49

44.09

3.4

3.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

393

1226

2.21

43.76

1.3

1.4

624.11

693.82

mu/l

0.25

368

1170

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

867

3540

1.69

43.64

1.1

33.72

28.27

au/ml

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

853

3469

1.70

43.56

1.1

37.03

72.52

au/ml

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

467

1564

2.06

43.50

1.6

1.5

22.03

25.88

umol/l

1.97

441

1489

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.58

43.10

1.1

—

mmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3083

16258

1.32

42.90

2.6

2.3

5327.86

6111.82

u/l

0.64

981

6763

(3017315) Amylase [Enzymatic activity/volume] in Urine

491

1691

2.01

42.43

1.3

1.2

251.14

330.51

u/l

1.09

456

1583

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1381

6355

1.51

42.21

1.2

123.16

129.92

titre

0.06

133

(3021367) Citalopram [Moles/volume] in Serum or Plasma

11.27

41.87

1.5

1.4

146.00

123.52

nmol/l

0.38

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

953

4039

1.63

41.63

1.3

1.4

440.13

352.65

pmol/l

0.37

815

3538

(3023323) Follitropin [Units/volume] in Serum or Plasma

3384

18156

1.30

41.48

1.4

1.3

24.97

27.12

iu/l

3.38

2793

15771

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2064

10285

1.39

41.39

1.7

0.23

g/l

0.22

1949

9759

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3254

17375

1.30

41.34

3.0

2.6

0.25

0.28

e6/l

0.75

3165

16880

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2094

10468

1.39

41.20

2.0

1.7

40.19

41.30

nmol/l

1.20

2026

10244

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1847

9041

1.42

41.04

1.4

1.5

16.65

13.59

iu/ml

0.36

215

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

21.19

40.97

3.3

2.5

354.78

370.15

nmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

49434

329479

1.15

40.55

4.2

3.7

1.41

1.28

mmol/l

234.37

44488

305947

(3044242) Glucose [Moles/volume] in Arterial blood

410

1347

2.10

40.20

2.5

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

462

1589

2.01

40.10

1.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1418

6637

1.48

39.92

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

464

1603

2.00

39.79

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1859

9160

1.41

39.79

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

398

1301

2.11

39.54

2.6

2.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

159

325

3.37

39.44

3.4

3.1

39.85

43.22

umol/l

0.97

141

270

(40768443) Skin Pathology biopsy report

2756

14476

1.32

39.39

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

487

1722

1.95

39.13

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

883

3733

1.64

38.99

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2101

10610

1.38

38.87

1.7

1.19

1.17

g/l

2.31

1987

10103

(3017509) Phencyclidine [Presence] in Urine

171

370

3.19

38.85

2.3

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

768

3134

1.69

38.80

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2703

14231

1.32

37.98

1.8

2.0

39.32

39.36

u/l

0.03

2369

12754

(3006922) Hepatitis E virus Ab [Presence] in Serum

608

2342

1.79

37.57

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

436

5627

0.53

37.45

4.5

2.4

13.29

13.14

2.44

428

5558

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1887

9424

1.39

37.34

1.3

32.02

36.84

u/ml

0.31

575

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

807

3372

1.66

37.32

1.2

58.49

64.05

u/l

1.18

724

3037

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1305

6106

1.48

36.82

3.1

3.3

565.30

850.38

u/ml

0.55

1165

5553

(3037756) Immunofixation for Serum or Plasma

1314

6161

1.48

36.69

1.6

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

565

2145

1.82

36.62

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

270

774

2.41

36.54

1.4

1.2

134.85

125.97

nmol/l

0.36

190

583

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

473

1697

1.93

36.48

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

226

595

2.62

36.41

1.1

0.82

3.04

umol/24h

0.48

311

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

566

2155

1.81

36.35

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1273

5945

1.48

36.27

3.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3108

16782

1.29

36.20

1.1

210.84

198.74

titre

0.06

458

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

627

2466

1.76

36.14

1.1

291.92

410.29

mg/l

0.49

551

2227

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

499

1831

1.88

35.99

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

444

1568

1.96

35.86

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2270

11756

1.34

35.71

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2071

10577

1.36

35.69

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

443

1567

1.95

35.62

1.8

—

(3049717) Cytology report of Urine Cyto stain

2253

11676

1.34

35.28

2.5

2.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

310

961

2.23

35.18

1.3

1.2

19.00

21.06

0.16

176

(3005322) IgE [Units/volume] in Serum or Plasma

3994

22343

1.25

34.59

1.3

249.73

242.77

u/ml

0.09

3662

20736

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

51335

343899

1.14

34.54

4.8

4.1

4.61

4.69

mmol/l

51.61

46816

322619

(4146454) Self-monitoring of blood glucose

760

3214

1.63

33.59

2.6

2.8

—

(3002256) Pathology report gross observation

7435

44277

1.18

33.44

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

693

2869

1.67

33.26

3.8

3.7

—

(3032057) Clostridioides difficile [Presence] in Stool

221

603

2.53

33.22

1.8

1.9

—

(3022621) pH of Urine by Test strip

3910

21930

1.24

33.03

3.5

2.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

829

3598

1.59

32.99

1.9

28.97

23.58

ug/l

0.71

811

3526

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3188

17515

1.27

32.24

3.5

3.1

66.72

46.80

u/ml

1.18

3067

16921

(3000012) Reticulocyte production index

942

4234

1.54

32.21

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2483

13292

1.30

30.86

1.7

1.6

3.96

3.84

mg/l

0.24

2018

9395

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1734

8814

1.36

30.82

3.1

3.5

1.56

1.51

mg/l

1.61

1567

8148

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

811

3565

1.57

30.62

3.1

3.3

6.15

7.38

nmol/l

0.30

782

3459

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

349

1207

2.00

30.01

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1148

5456

1.46

30.00

1.5

1.6

0.70

0.76

g/l

1.00

844

4124

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

560

2252

1.72

29.97

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

349

1208

1.99

29.94

2.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

408

1491

1.89

29.91

1.5

1.6

2.78

8.70

nmol/l

0.90

339

1248

(3039443) Prostate specific Ag panel - Serum or Plasma

576

6485

0.61

29.88

1.7

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

212

598

2.44

29.82

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

352

1225

1.98

29.75

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

50889

341458

1.13

29.61

4.7

4.1

1.42

1.46

mmol/l

91.69

46195

319013

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

287

927

2.14

29.56

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

288

933

2.13

29.45

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

526

2089

1.74

29.44

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1098

5198

1.46

29.29

1.6

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

560

2270

1.70

29.14

1.2

—

(4062490) Immunoglobulin typing, IgG

783

3455

1.57

29.11

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

782

3450

1.57

29.10

1.3

1.4

6.66

6.78

g/l

0.34

531

2396

(3047181) Lactate [Moles/volume] in Blood

1970

10299

1.33

29.07

6.4

5.5

1.35

1.30

mmol/l

1.40

1774

9090

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1707

8736

1.35

29.06

1.3

7.80

8.69

u/ml

0.23

253

1378

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

958

4427

1.50

28.83

2.6

2.7

129.97

821.89

u/ml

1.86

943

4373

(3044927) Protein electrophoresis panel - Urine

668

2844

1.62

28.83

1.3

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

779

3447

1.56

28.62

1.3

1.4

0.37

0.41

g/l

1.93

536

2401

(3028192) IgG subclass 2 [Mass/volume] in Serum

779

3449

1.56

28.55

1.3

1.4

2.90

2.98

g/l

0.62

531

2396

(40757494) Bilirubin.total [Moles/volume] in Blood

426

1605

1.83

28.44

2.1

19.16

32.44

umol/l

1.21

153

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

429

1621

1.83

28.38

1.3

59.28

64.03

0.42

192

(3029634) Reagin Ab [Titer] in Serum by VDRL

1075

5101

1.46

28.35

2.1

5.63

7.26

titre

0.31

144

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

889

2.13

28.30

3.5

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

889

2.13

28.30

3.5

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

215

627

2.36

28.18

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

494

1957

1.74

27.92

1.6

6.62

6.98

u/l

0.23

386

1579

(3002385) Erythrocyte distribution width [Ratio]

46058

307588

1.11

27.83

23.5

14.9

15.13

14.98

1.63

45345

302056

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

467

1824

1.77

27.72

1.4

1.3

—

(3036489) Thrombin time

2397

12955

1.28

27.66

2.0

2.1

21.29

21.46

0.55

2075

11206

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

852

3879

1.52

27.55

2.1

2.2

32.66

32.62

0.08

844

3850

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3830

21869

1.22

27.16

2.0

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

374

1372

1.88

27.16

3.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

439

1694

1.79

27.15

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

957

4477

1.48

27.15

1.1

1.54

1.49

g/l

2.39

839

4081

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1670

8621

1.34

26.88

1.3

7.21

6.41

u/ml

0.14

164

909

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1565

8009

1.35

26.68

1.2

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

317

1106

1.98

26.67

1.9

2.4

1.06

1.10

ug/l

0.11

297

1036

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

156

400

2.69

26.61

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

651

2812

1.60

26.54

1.2

1.1

36.25

44.23

mg/l

3.42

527

2362

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

516

2101

1.70

26.48

3.1

3.3

112.29

132.00

nmol/l

0.81

498

2070

(3045414) Leukocytes [Presence] in Urine

2737

15115

1.26

26.45

1.9

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1956

10359

1.31

26.34

2.5

2.6

3.65

3.62

g/l

0.44

1842

9890

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4589

26734

1.20

26.33

2.8

2.6

68.04

67.09

ml/min/173m2

0.79

1934

10394

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.04

25.97

1.7

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

465

1861

1.72

25.42

1.1

1.86

5.66

nmol/l

2.17

372

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

627

2715

1.60

25.33

1.1

250.71

268.27

mg/l

0.79

539

2391

(3051651) Icteric interference index of Serum or Plasma

471

1894

1.72

25.32

3.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1388

7056

1.36

24.72

1.2

44.31

43.16

u/ml

0.08

128

703

(3004451) EKG impression Narrative

372

1414

1.82

24.24

1.3

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

654

2895

1.56

24.09

4.0

3.7

42.21

48.49

u/ml

0.36

645

2861

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

126

304

2.86

24.08

2.2

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

865

4065

1.47

24.05

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

730

3323

1.52

23.71

3.5

3.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

408

1607

1.75

23.63

1.1

82.16

84.61

u/l

0.22

370

1451

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

408

1608

1.75

23.58

1.1

22.07

24.54

u/l

0.30

369

1451

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

516

2170

1.64

23.50

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

103

224

3.17

23.44

1.6

1.8

51.67

44.21

umol/l

1.24

103

224

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2381

13124

1.26

23.39

5.7

4.8

1.83

1.67

7.16

2242

12302

(1002224) Polysomnography panel

2667

14891

1.24

23.39

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1343

6856

1.36

23.31

5.1

5.8

942.74

1730.75

iu/ml

0.55

167

1034

(40768793) Breast Pathology biopsy report

1392

7154

1.35

23.13

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1373

7051

1.35

22.93

1.2

2.85

5.89

u/ml

1.55

552

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1532

8001

1.33

22.83

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2040

11073

1.28

22.78

3.3

3.4

903.01

1953.30

u/ml

0.87

1755

9493

(3002079) Sodium [Moles/time] in 24 hour Urine

388

1524

1.76

22.71

1.2

154.40

159.64

mmol/24h

0.58

388

1524

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1358

6979

1.35

22.58

1.2

12.45

14.82

u/ml

0.09

(3000093) Morphology [Interpretation] in Blood Narrative

670

3027

1.53

22.56

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

8.31

22.42

1.3

159.72

198.82

nmol/l

0.37

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

249

3247

0.53

22.36

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3242

18574

1.21

22.17

1.3

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

231

771

2.07

22.04

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

553

2406

1.59

21.99

2.6

2.5

746.66

683.73

e6/l

1.09

519

2342

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1041

5166

1.39

21.55

2.4

2.9

1538.44

6359.50

u/ml

0.99

284

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1151

5808

1.37

21.54

1.5

1.4

0.36

0.42

nmol/l

1.18

878

4618

(3024869) Neuronal Ab [Presence] in Serum

174

523

2.29

21.47

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7827

59997

0.88

21.31

3.0

2.9

0.70

0.77

ug/l

5.12

5237

38321

(3001186) Copper [Moles/volume] in Serum or Plasma

229

776

2.03

21.02

1.3

17.12

16.79

umol/l

0.44

199

695

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

291

3559

0.56

20.99

1.5

1.6

8.19

7.65

mmol/l

3.32

286

3412

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

452

1894

1.65

20.95

1.1

1.05

1.07

u/l

0.28

185

875

(3028433) Virus identified in Specimen by Culture

285

1047

1.88

20.77

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

630

2861

1.52

20.76

1.4

1.3

1.58

1.41

nmol/l

3.02

563

2593

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4668

27774

1.17

20.72

2.2

1.9

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

104

246

2.91

20.65

2.0

1.29

1.32

umol/l

0.45

221

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11063

83010

0.90

20.60

4.2

4.1

21.63

22.00

1.53

4867

38839

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

591

2653

1.54

20.55

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2102

11602

1.26

20.43

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1692

9096

1.29

20.42

1.9

2.1

10.88

10.84

mg/l

0.06

1548

8532

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

389

1580

1.70

20.30

1.1

5.71

10.67

u/ml

3.24

278

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

132

359

2.53

20.21

2.2

1.9

—

(4034850) Laboratory test

1960

10751

1.26

20.10

12.4

9.0

—

(3045716) Anion gap in Serum or Plasma

349

1380

1.74

20.04

2.4

9.41

9.91

mmol/l

1.78

338

1342

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

503

2191

1.58

19.96

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2309

12917

1.24

19.91

5.8

4.9

0.87

0.90

1.84

2174

12107

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1605

14021

0.78

19.48

1.8

1.9

—

(3016244) Insulin [Units/volume] in Serum or Plasma

498

2181

1.58

19.34

3.1

3.2

30.74

27.18

mu/l

1.03

459

2054

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

426

1801

1.63

19.13

1.9

1.7

2.44

2.33

u/field

0.10

317

1283

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

754

3614

1.44

19.05

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1115

5728

1.35

18.67

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

216

750

1.99

18.62

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1142

5891

1.34

18.61

1.8

1.9

4.80

5.27

mmol/24h

4.80

980

5274

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

201

681

2.03

18.53

1.5

1.6

0.39

0.40

ug/l

0.10

122

460

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

440

1892

1.60

18.48

1.3

1.5

6.29

5.82

u/l

0.31

351

1604

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1025

5207

1.36

18.47

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

263

980

1.85

18.42

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1359

7200

1.31

18.36

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

176

571

2.12

18.18

2.3

2.5

6.82

7.60

mmol/l

1.85

110

338

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

560

2558

1.51

18.04

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

743

3601

1.42

17.71

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

316

1262

1.73

17.61

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9823

61917

1.11

17.60

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

442

1939

1.57

17.11

1.2

94.97

90.43

u/l

0.37

383

1712

(3038026) Centromere Ab [Units/volume] in Serum

568

2634

1.49

17.06

1.2

48.43

51.30

u/ml

0.05

123

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

431

1882

1.58

17.03

1.2

25.47

24.55

u/l

0.13

363

1640

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

223

811

1.90

16.87

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

223

811

1.90

16.87

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

317

1285

1.70

16.78

1.1

1197.86

436.53

ng/l

0.50

306

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

482

2168

1.53

16.73

1.4

11.89

12.85

u/l

2.46

462

2097

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1808

10042

1.25

16.69

2.3

2.6

191.15

184.88

2.00

1690

9525

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

723

3528

1.42

16.63

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

723

3530

1.41

16.58

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

443

1960

1.56

16.55

1.4

1.2

4.79

5.15

umol/l

1.19

406

1810

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

220

802

1.89

16.54

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

477

2153

1.53

16.31

1.5

24.91

24.87

u/ml

0.00

429

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

160

525

2.10

16.12

1.2

1.4

130.58

242.52

ng/l

0.31

357

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

221

814

1.87

16.12

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

551

2571

1.48

16.09

1.2

85.65

63.71

u/ml

1.08

105

(3010503) CD19 cells [#/volume] in Blood

448

2002

1.54

16.04

2.8

2.5

0.16

0.36

e9/l

2.29

430

1956

(3021788) Differential panel - Synovial fluid

1125

5921

1.31

16.02

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

551

2578

1.47

15.88

1.2

42.86

46.69

u/ml

0.15

179

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

530

2464

1.48

15.77

1.2

6.31

10.33

u/ml

0.49

159

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1266

6789

1.29

15.69

1.2

1.3

272.93

263.68

u/ml

0.55

790

4471

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

419

1858

1.56

15.54

1.3

202.26

489.40

titre

1.90

134

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1947

10989

1.23

15.51

2.1

2.3

93.01

92.40

0.52

1852

10541

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

170

580

2.02

15.48

1.4

1.6

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

244

2.63

15.42

1.3

1.4

15.37

12.28

pmol/l

0.22

203

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

449

2028

1.53

15.34

2.1

2.0

99.88

98.10

0.45

414

1890

(21494815) CD4 cells/100 lymphocytes in Specimen

609

2930

1.43

15.20

2.3

2.1

40.23

38.50

2.06

593

2879

(3027923) C peptide [Moles/volume] in Serum or Plasma

399

1762

1.56

15.09

1.6

1.31

1.24

nmol/l

0.57

304

1404

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1341

7282

1.27

15.06

1.4

17.40

19.81

u/ml

0.27

141

(3000475) Leukocytes [#/volume] in Synovial fluid

1419

7770

1.26

14.88

1.7

1.6

13574.09

13168.58

e6/l

0.10

982

5720

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

198

723

1.89

14.88

1.3

1.2

422.35

296.68

pmol/l

0.77

133

545

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

550

2607

1.46

14.87

2.2

1.9

2.43

2.26

u/field

0.26

282

1119

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.51

14.83

1.5

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1658

9251

1.24

14.74

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

152

507

2.07

14.73

1.9

1.20

1.19

mmol/l

0.52

147

484

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

513

2404

1.47

14.71

1.4

12.19

12.08

umol/l

0.12

475

2291

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

612

2968

1.42

14.65

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

326

1383

1.63

14.59

7.2

10.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

405

1809

1.54

14.59

1.3

48.70

80.00

titre

1.18

163

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1226

6616

1.28

14.50

1.9

2.2

0.89

0.84

nmol/l

1.79

991

5582

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

323

2.35

14.49

1.1

—

(40768441) Liver Pathology biopsy report

502

2353

1.47

14.39

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

572

2752

1.43

14.31

1.2

130.00

192.34

titre

1.37

462

(40768806) Pleura Pathology biopsy report

621

3033

1.41

14.30

1.5

—

(3011412) CD3 cells [#/volume] in Blood

664

3281

1.40

14.30

2.5

2.4

1.29

1.20

e9/l

1.26

596

2936

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

569

2746

1.43

14.02

1.2

72.11

194.13

titre

2.62

(3028308) Erythrocytes [#/volume] in Pleural fluid

650

3215

1.40

13.93

1.5

63682.61

53729.53

e6/l

0.30

402

1921

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

387

2.19

13.84

2.7

2.4

0.67

0.57

u/field

0.53

123

387

(3001019) Free T4 and TSH panel - Serum or Plasma

2560

20608

0.85

13.73

1.8

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

707

3557

1.37

13.69

1.5

4853.36

2978.12

e6/l

0.69

523

2577

(3034988) Calcium [Moles/volume] in Capillary blood

157

547

1.98

13.57

1.8

2.0

1.18

mmol/l

0.28

150

523

(3003434) Protein [Mass/volume] in Pleural fluid

774

3956

1.35

13.56

1.5

34.03

32.83

g/l

1.86

704

3555

(3035320) C reactive protein [Mass/volume] in Body fluid

504

2399

1.45

13.39

3.0

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1333

7352

1.25

13.19

1.4

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

174

639

1.88

12.93

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

469

2218

1.46

12.91

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

272

1139

1.65

12.89

1.2

113.05

110.87

0.64

239

1020

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

152

535

1.96

12.80

2.3

2.6

29.64

59.83

mg/l

1.47

(3012441) Differential panel - Pleural fluid

613

3049

1.39

12.77

1.5

—

(3044941) Cell count panel - Synovial fluid

938

4974

1.30

12.76

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

690

3499

1.36

12.76

2.4

2.5

1.13

1.34

g/24h

1.39

329

1795

(3022493) Free Hemoglobin [Mass/volume] in Plasma

318

1389

1.58

12.71

3.9

5.1

1353.78

2619.45

mg/l

0.61

218

994

(3035947) Staphylolysin Ab [Units/volume] in Serum

364

1644

1.53

12.56

1.1

3.81

4.10

iu/ml

0.19

128

(3003129) Base excess in Capillary blood by calculation

195

751

1.79

12.48

1.9

1.6

1.07

0.39

mmol/l

1.55

182

710

(3028717) Thiamine [Mass/volume] in Blood

102

312

2.25

12.33

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

222

892

1.72

12.30

2.2

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

926

4930

1.30

12.25

1.3

32.19

35.26

u/l

0.38

792

4309

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

488

2358

1.43

12.03

2.5

551.51

528.16

e6/l

0.39

404

1981

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

148

528

1.93

12.02

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

246

1023

1.66

12.02

3.3

3.0

—

(3006270) Folate [Moles/volume] in Blood

555

2745

1.39

11.99

1.2

1.1

365.06

370.03

nmol/l

0.21

471

2324

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

348

2.16

11.91

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1397

7841

1.23

11.84

1.4

174.68

117.47

pmol/l

2.08

1363

7643

(3019420) Tryptase [Mass/volume] in Serum or Plasma

398

1860

1.48

11.70

1.5

8.40

7.83

ug/l

0.18

359

1686

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

935

5020

1.29

11.62

4.0

3.5

49.10

35.47

u/ml

1.11

899

4851

(3014051) Protein [Presence] in Urine by Test strip

1523

8647

1.22

11.56

2.6

2.4

—

(40762365) Oxygen content in Arterial blood by calculation

139

494

1.94

11.45

2.9

3.1

14.61

14.83

ml/dl

0.39

129

458

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

510

2507

1.40

11.44

1.2

1.3

1.43

1.92

u/ml

0.69

286

1394

(3039000) Anion gap in Blood

1286

7184

1.24

11.41

7.8

6.5

11.19

11.26

mmol/l

0.26

1180

6461

(3018572) Chloride [Moles/volume] in Blood

1286

7185

1.24

11.40

7.8

6.5

104.66

105.19

mmol/l

3.02

1180

6463

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

280

1221

1.58

11.34

2.6

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

173

2.63

11.10

1.1

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

537

2681

1.38

11.02

1.3

576.15

473.31

u/l

0.45

499

2544

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

280

1233

1.57

10.90

1.2

0.32

0.30

g/l

2.11

224

971

(40768800) Prostate Pathology biopsy report

689

6206

0.76

10.84

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

297

1331

1.54

10.71

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

122

425

1.98

10.67

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

515

2569

1.38

10.64

2.0

1.7

7.07

6.64

mmol/l

2.00

376

1908

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

123

433

1.96

10.46

1.1

—

(3000492) Spirometry study

5589

35103

1.10

10.43

1.5

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

554

2807

1.36

10.41

1.3

6.16

6.32

mmol/l

0.66

498

2611

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

734

1.72

10.30

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

310

2.13

10.27

1.1

1.73

2.90

umol/24h

0.50

310

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

292

1320

1.52

10.15

2.7

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

464

2294

1.39

10.14

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9326

60028

1.08

10.00

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

312

1436

1.50

9.98

1.8

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1205

6794

1.22

9.87

1.4

1.5

109.98

111.24

u/ml

0.12

288

1544

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

129

472

1.88

9.83

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

133

492

1.86

9.80

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10840

70240

1.07

9.72

1.7

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

164

652

1.73

9.56

1.4

1.3

73.65

76.79

mu/l

0.06

109

506

(3012565) Volume of 24 hour Urine

351

1672

1.45

9.47

2.0

2.2

1974.46

1984.09

0.05

305

1504

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

741

3984

1.28

9.23

1.2

1.1

1.96

1.95

iu/ml

0.00

(3006576) Bicarbonate [Moles/volume] in Blood

248

1109

1.54

9.12

5.4

6.3

25.02

25.05

mmol/l

0.04

228

1006

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1498

8694

1.19

9.10

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

900

0.44

9.05

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

532

2742

1.34

9.02

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1718

10102

1.18

8.95

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

279

1287

1.49

8.89

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

157

2.50

8.78

1.6

1.7

0.66

0.73

umol/l

0.47

121

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.95

8.78

1.0

1.1

215.86

205.26

pmol/l

0.05

(3009542) Hematocrit [Volume Fraction] of Blood

57883

395072

1.09

8.68

30.1

18.5

39.81

40.57

36.53

54663

371450

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

314

1491

1.45

8.67

2.8

3.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

201

868

1.60

8.62

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

245

1108

1.52

8.59

1.7

1.6

39734.43

21174.27

u/ml

0.20

137

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

454

2306

1.36

8.51

2.6

2.5

0.23

e9/l

0.10

397

1986

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

189

807

1.61

8.49

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

176

739

1.64

8.46

1.8

1.3

12.84

13.62

g/l

0.49

125

569

(21491868) Cryoglobulin [Mass/volume] in Serum

250

1142

1.51

8.38

1.3

1.2

0.93

0.49

g/l

—

(44813793) Dust mix specific IgE antibody measurement

488

2516

1.34

8.30

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

893

4974

1.24

8.29

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

196

2.28

8.28

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

150

608

1.70

8.24

1.4

1.6

—

(3001556) Androgen free Index in Serum or Plasma

105

384

1.88

8.10

1.4

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

227

1024

1.53

8.09

1.4

58.95

62.76

0.87

194

828

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

8.07

3.9

0.0

299.89

—

umol/l

—

(4281824) Cell count and differential, peritoneal fluid

634

3407

1.28

8.00

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

973

5495

1.22

7.95

1.1

11.25

11.37

au/ml

0.01

373

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

965

5454

1.22

7.83

1.1

11639.23

476.33

iu/ml

0.59

228

1218

(3039162) Centromere protein B Ab [Units/volume] in Serum

781

4316

1.25

7.82

1.2

65.28

48.86

u/ml

0.84

279

(40761995) Spermatozoa Progressive [#/volume] in Semen

960

0.50

7.77

3.1

3.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1719

10229

1.16

7.76

1.1

2.91

5.57

u/ml

4.29

165

1424

(21494890) Protein electrophoresis panel - 24 hour Urine

591

3161

1.29

7.76

2.1

2.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

140

567

1.70

7.75

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

959

0.50

7.75

6.1

6.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

115

440

1.80

7.73

1.2

1.4

44.00

53.01

1.04

214

(3003694) ABO and Rh group [Type] in Blood

14430

103740

0.94

7.73

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

197

872

1.56

7.67

1.4

3.13

2.62

0.37

177

718

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

209

938

1.54

7.65

2.2

1.8

4801.33

13445.09

e6/l

2.19

125

488

(1617658) Protocol used for examination of sentinel lymph nodes

450

2325

1.33

7.60

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1830

10962

1.15

7.56

1.7

1.6

1.75

7.17

iu/ml

1.48

372

2315

(3037692) Legionella sp identified in Specimen by Organism specific culture

234

1080

1.49

7.53

1.4

1.5

—

(3007461) Platelets [#/volume] in Blood

57901

395454

1.09

7.51

30.0

18.4

256.71

252.33

e9/l

45.25

56631

385424

(3000919) Neutrophils/100 leukocytes in Pleural fluid

180

785

1.58

7.48

1.4

25.88

21.01

1.42

165

707

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

245

1145

1.47

7.42

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

342

1.89

7.41

2.1

2.6

0.78

1.28

mmol/l

2.11

245

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

254

1197

1.46

7.38

1.1

113.90

108.53

1.20

227

1086

(3027974) Hepatitis B virus e Ag [Presence] in Serum

198

2.19

7.34

1.2

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

167

719

1.60

7.33

1.1

—

(3051339) Copper [Moles/volume] in Blood

155

2.35

7.27

1.2

1.3

16.95

16.49

umol/l

0.32

132

(3052592) Norovirus Ag [Presence] in Stool

149

627

1.64

7.18

1.4

1.3

—

(3008898) HLA-B27 [Presence]

2087

12666

1.14

7.15

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.99

7.11

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

126

509

1.70

7.08

1.1

1.88

7.66

pmol/l

0.90

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1337

7861

1.17

7.08

2.1

2.3

123.64

109.61

ug/min

0.44

762

4739

(3019832) Treponema pallidum Ab [Presence] in Serum

5758

42563

0.92

7.06

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

211

2.12

7.02

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

244

1153

1.46

7.02

1.1

97.03

90.86

1.41

123

541

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

315

1560

1.39

7.00

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

272

1.97

6.98

1.5

1.6

2.12

1.71

mg/l

0.29

168

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.44

6.96

1.3

74.75

47.13

e6/l

0.26

(3023487) Leukocytes [#/volume] in Peritoneal fluid

228

1065

1.47

6.96

2.3

1.9

3517.35

3359.28

e6/l

0.02

161

716

(40759632) Porphyrins [Mass/mass] in Stool

4.59

6.89

1.1

—

(3035880) pH of Pleural fluid

322

1612

1.38

6.73

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

462

2443

1.30

6.69

1.9

1.8

3.59

3.78

mg/l

0.46

425

2340

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

332

1674

1.37

6.64

1.7

1.9

152.53

140.09

1.70

316

1570

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

697

5892

0.81

6.61

1.3

3.00

3.61

ug/l

2.15

596

5329

(3016228) CD19 cells/100 cells in Blood

274

1339

1.41

6.60

2.2

2.0

7.78

8.63

0.72

263

1311

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

226

2.04

6.58

1.1

7.54

10.36

u/l

0.91

226

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

247

1186

1.43

6.56

1.1

93.77

90.21

1.03

120

558

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

337

1.84

6.56

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.79

6.53

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

179

1836

0.67

6.49

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

151

656

1.59

6.45

1.5

1.3

36.02

35.21

g/l

0.02

111

513

(40763480) Human metapneumovirus Ag [Presence] in Specimen

143

2.31

6.38

1.3

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

139

2.33

6.35

1.5

0.13

0.21

u/l

0.23

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

7.37

6.33

1.1

80.65

29.47

umol/l

—

(3035941) MCH [Entitic mass]

57907

395776

1.08

6.32

29.8

18.3

30.34

30.24

32.11

57048

390572

(1175426) CD3 cells/100 lymphocytes in Blood

490

2634

1.28

6.29

2.1

2.0

74.49

72.68

2.20

465

2534

(3010370) Gastrin [Moles/volume] in Serum or Plasma

122

506

1.66

6.28

1.4

1.8

75.45

50.06

pmol/l

0.31

101

425

(3028679) Herpes simplex virus Ab [Presence] in Serum

383

1992

1.33

6.28

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

630

1.59

6.21

1.1

1.2

—

(3024731) MCV [Entitic volume]

57909

395829

1.08

6.16

29.9

18.3

91.22

90.68

150.74

57050

390612

(3017704) Immunofixation for Urine

324

1649

1.35

6.15

1.7

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

210

992

1.46

6.12

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

57917

395898

1.08

6.11

30.1

18.4

6.99

6.70

e9/l

131.93

56483

384784

(3026361) Erythrocytes [#/volume] in Blood

57911

395864

1.08

6.08

30.0

18.4

4.43

4.52

e12/l

307.65

56474

384773

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

0.58

0.93

mg/l

0.82

171

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

1.93

2.04

mg/l

0.06

166

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

1.24

1.35

mg/l

0.07

153

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

2.00

1.83

mg/l

0.11

184

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

2.04

1.96

mg/l

0.03

154

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

2.55

2.29

mg/l

0.17

174

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

4.10

3.79

mg/l

0.14

162

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

2.12

2.71

mg/l

0.40

180

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

267

1.91

6.07

1.5

1.6

1.53

2.31

mg/l

0.86

187

(21494814) CD8 cells/100 lymphocytes in Specimen

265

1314

1.39

5.93

2.2

2.0

—

(3030313) Adrenal Ab [Titer] in Serum

334

1.79

5.90

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

131

2.31

5.88

1.1

673.97

322.54

u/l

0.57

112

(3048879) Bone marrow aspiration report

186

866

1.48

5.85

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

351

1.77

5.80

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

186

2.07

5.78

1.1

1.11

1.20

u/field

0.42

127

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

248

1.92

5.74

2.6

2.1

55.00

59.68

0.41

155

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

358

1.75

5.71

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

121

515

1.62

5.68

1.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

197

2.03

5.65

1.3

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

325

1680

1.33

5.61

2.0

2.3

198.51

203.67

u/l

0.53

325

1666

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

489

2670

1.26

5.59

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

57912

396001

1.07

5.57

30.2

18.5

133.57

136.03

g/l

299.24

57047

390832

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

403

2150

1.29

5.55

1.3

14.74

13.82

u/l

0.27

370

1985

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

489

2673

1.26

5.54

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

488

2667

1.26

5.54

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

884

5134

1.19

5.53

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

451

2444

1.27

5.50

2.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

118

504

1.61

5.48

1.4

0.22

0.27

nmol/l

1.04

353

(3000034) Microalbumin [Mass/volume] in Urine

532

2944

1.25

5.43

3.1

3.0

53.54

57.29

mg/l

0.11

394

2094

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

491

2696

1.26

5.37

1.2

—

(3000285) Sodium [Moles/volume] in Blood

370

1.71

5.37

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

475

2600

1.26

5.34

2.0

13.90

15.20

2.24

461

2528

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

214

1044

1.41

5.31

2.2

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

491

2700

1.25

5.31

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

490

2695

1.25

5.29

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

14605

104076

0.96

5.20

4.8

4.7

3.25

3.20

ug/l

0.05

12734

93983

(3013336) Amino acids [Identifier] in Serum or Plasma

2.95

5.14

3.0

2.9

—

(3025130) Human papilloma virus identified in Specimen

897

5254

1.18

5.12

1.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

326

1712

1.31

5.09

1.1

1.2

15.12

12.26

u/ml

0.14

167

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

564

3169

1.23

5.04

3.6

4.9

59.32

114.91

u/ml

2.66

124

1055

(3013466) aPTT in Blood by Coagulation assay

211

1.93

5.03

1.0

1.1

35.82

37.20

0.91

178

(3016750) Collection duration of Urine

357

1903

1.29

5.00

2.1

2.2

511.85

498.16

min

1.55

248

1432

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

142

648

1.51

5.00

5.7

6.1

67.06

70.96

0.90

107

517

(3023420) DNA double strand Ab [Units/volume] in Serum

667

3820

1.20

4.93

1.5

1.6

24.48

35.26

iu/ml

1.61

186

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

320

1685

1.31

4.92

7.9

5.7

854.64

3446.86

u/ml

0.65

318

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

113

494

1.58

4.83

4.4

4.7

54.99

44.31

ug/min

0.96

388

(3013727) Leukocytes other/100 leukocytes in Blood

212

1052

1.39

4.82

2.7

3.6

51.68

53.03

0.36

206

1016

(3008536) Aspergillus sp Ab [Presence] in Serum

135

615

1.51

4.81

2.0

2.2

—

(3049233) Organic acids panel - Urine

3.55

4.80

1.4

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

109

2.27

4.70

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

285

1487

1.32

4.70

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6355

41409

1.06

4.68

1.6

1.8

—

(3006462) Nitrate [Presence] in Urine

308

1628

1.30

4.64

3.5

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1972

12267

1.11

4.60

1.4

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

106

463

1.58

4.57

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

129

2.13

4.52

1.3

1.30

1.01

u/field

1.19

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

555

3153

1.21

4.50

1.5

30.48

31.27

0.19

327

2003

(3006567) Chloride [Moles/time] in 24 hour Urine

2.86

4.49

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

653

5336

0.84

4.49

1.3

1.4

7.48

7.00

mmol/l

4.05

599

4724

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

297

1.72

4.43

1.1

1.0

—

(21494434) Karyotype in Bone marrow

470

2630

1.23

4.43

1.1

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

110

490

1.55

4.38

2.7

2.8

1192.26

1847.17

u/l

0.52

439

(4094501) Cardiovascular stress test using bicycle ergometer

1450

8896

1.12

4.35

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

193

1.89

4.34

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

870

5159

1.16

4.33

1.3

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

228

1.81

4.32

3.6

2.9

93.21

381.67

pmol/l

0.43

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

165

1.96

4.28

1.4

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

110

493

1.54

4.27

1.0

0.05

0.36

u/ml

1.77

301

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

306

1.69

4.25

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

887

5276

1.16

4.25

1.1

119.42

118.09

0.53

785

4798

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

356

1942

1.26

4.23

2.8

2.7

39.91

39.54

0.13

170

1097

(37019676) Renin [Units/volume] in Plasma --supine

2.62

4.22

1.0

1.1

57.52

57.08

mu/l

0.00

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

915

5461

1.16

4.19

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

829

1.40

4.17

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

174

858

1.40

4.17

1.9

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

104

463

1.55

4.17

1.2

1.3

41.25

41.40

mg/l

0.01

396

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

431

1.57

4.15

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

154

744

1.43

4.14

1.1

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

172

1.92

4.14

1.3

1288.70

905.03

u/l

0.13

152

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

125

2.09

4.12

1.2

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

362

1.62

4.11

1.1

—

(3013762) Body weight Measured

121

2.10

4.08

1.2

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.32

4.01

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

270

2386

0.78

3.99

1.8

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

199

1.83

3.99

1.0

0.09

0.61

u/ml

1.89

184

(3010144) Erythrocytes [#/volume] in Synovial fluid

534

3062

1.20

3.99

1.4

89411.43

110347.15

e6/l

0.41

364

2114

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

235

1.76

3.95

1.1

1.2

21.50

23.59

—

(3024263) Appearance of Synovial fluid

314

1703

1.27

3.95

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

706

4155

1.17

3.92

1.5

1.6

56.13

56.92

0.19

422

2678

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

109

498

1.51

3.91

1.0

86.33

80.74

ug/l

0.67

411

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

206

1.80

3.88

1.4

1.5

7.46

14.55

3.18

147

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.61

3.86

1.1

2.36

2.55

0.13

(44786800) Granulocytes/100 leukocytes in Body fluid

358

1.60

3.84

1.3

23.35

24.85

0.16

266

(3014891) Appearance of Pleural fluid

402

1.56

3.81

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

115

536

1.48

3.77

1.2

1.66

1.68

mmol/l

0.07

325

(3002621) Streptococcal DNAse B [Units/volume] in Serum

291

1.66

3.75

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

234

1.74

3.74

1.2

17.38

15.18

nmol/l

0.30

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

261

1.69

3.69

1.4

1.3

1.22

1.44

ml/s/173m2

0.25

163

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

914

5512

1.14

3.67

1.3

1.2

3.35

3.94

u/ml

0.98

393

2475

(3005082) Progesterone [Moles/volume] in Serum or Plasma

271

2365

0.79

3.65

1.4

30.15

31.79

nmol/l

0.39

236

2180

(3029396) Erythrocyte agglutination [Presence] in Blood

130

1259

0.71

3.65

2.7

3.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

226

1188

1.31

3.65

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.29

3.59

1.1

1.0

16.80

15.15

umol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1185

7277

1.12

3.59

4.4

3.2

24.95

26.88

mg/l

0.99

700

4605

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

239

1.70

3.50

1.4

1.5

48.38

35.46

1.40

158

(3012898) Urea [Moles/volume] in Urine

340

1.58

3.49

1.7

1.6

168.64

169.09

mmol/l

0.01

303

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

101

2.11

3.49

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

251

1.67

3.43

1.3

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

158

0.30

3.41

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

581

0.59

3.39

5.9

5.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

150

1.88

3.39

1.1

1.2

0.31

0.95

umol/24h

1.32

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

414

2359

1.21

3.38

1.2

—

(3032641) Amino acids panel - Urine

3.31

3.38

1.2

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

102

476

1.48

3.37

1.5

1.4

201338.78

206540.42

nmol/l

0.01

398

(3001964) Herpes simplex virus Ag [Presence] in Specimen

197

1030

1.32

3.34

1.4

1.5

—

(3047189) Immunofixation for 24 hour Urine

252

1362

1.27

3.33

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

109

517

1.45

3.32

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1960

12402

1.09

3.32

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

179

925

1.33

3.30

1.5

1.6

9.77

8.94

ug/l

1.35

179

925

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

297

1.60

3.28

1.1

21.17

20.23

u/l

0.12

193

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

276

1517

1.25

3.19

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

278

1.61

3.18

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

155

789

1.35

3.17

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

155

789

1.35

3.17

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

155

789

1.35

3.17

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

155

789

1.35

3.17

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

205

1.71

3.15

1.5

1.3

25.88

15.15

pmol/l

1.00

171

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

190

1.74

3.13

1.1

44.14

84.24

u/l

0.61

149

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

211

1.70

3.11

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

324

1819

1.23

3.10

2.0

3.45

3.71

ug/l

0.19

292

1670

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

275

1517

1.25

3.10

1.3

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

178

929

1.32

3.09

1.2

38.36

40.47

g/l

1.21

516

(3045142) Bone marrow Pathology biopsy report

574

3396

1.16

3.08

1.2

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

435

1.47

3.07

1.4

11.55

11.82

0.03

207

(43055442) Apixaban [Mass/volume] in Serum or Plasma

385

1.50

3.06

1.5

1.6

104.29

112.29

ug/l

0.30

318

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

202

1.70

3.04

3.0

2.0

12.21

17.30

0.77

(3025577) Chromium [Mass/volume] in Blood

315

1768

1.23

3.03

2.0

2.1

2.31

2.33

ug/l

0.02

257

1486

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

399

2295

1.20

3.00

1.1

1.08

1.07

ratio

0.49

148

809

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

103

2.00

3.00

1.1

1.2

3829.67

3830.90

ng/l

0.00

(3020393) Adenovirus Ag [Presence] in Stool

343

1.53

2.98

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

290

1619

1.23

2.95

1.3

1.5

3.60

4.28

0.29

385

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

592

3524

1.16

2.95

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

417

1.47

2.93

1.8

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

292

1633

1.23

2.93

1.1

98.46

96.96

0.34

227

1309

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

184

1.72

2.91

1.1

1.33

3.11

u/l

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.48

2.91

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

155

802

1.33

2.89

1.3

285.15

260.72

ug/l

0.05

429

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

230

1260

1.26

2.79

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

197

1.68

2.79

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

116

1.90

2.78

2.4

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

434

1.44

2.76

2.4

2.6

70.33

71.01

pmol/l

0.01

376

(3045683) HLA typing for celiac disease panel - Blood or Tissue

384

2222

1.19

2.74

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

328

1.51

2.74

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

162

1.74

2.73

1.4

1.7

193.47

205.89

ng/l

0.36

139

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

926

5712

1.12

2.70

1.3

1.2

3.41

3.68

u/ml

0.17

294

1994

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

247

1.59

2.70

1.2

96.57

105.42

ug/l

0.17

157

(3043410) Blood group antigens tested for on Red Blood Cells

177

944

1.29

2.68

2.0

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

226

1243

1.25

2.67

1.8

2.0

167.79

163.66

0.21

218

1166

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

196

1697

0.79

2.60

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

104

515

1.39

2.59

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

340

1.48

2.53

3.4

2.9

1.20

1.35

mg/l

0.31

235

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

741

4534

1.13

2.52

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

285

1620

1.21

2.50

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

291

1.51

2.49

1.0

1.1

7.60

3.86

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

151

798

1.30

2.48

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

133

693

1.32

2.43

1.3

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

179

1.65

2.42

1.5

1.3

2.10

1.54

0.21

118

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.03

2.41

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

136

712

1.32

2.40

1.4

26.53

22.06

0.91

113

590

(3022475) Manganese [Moles/volume] in Blood

206

1.60

2.40

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

254

2119

0.82

2.40

1.0

0.46

0.96

u/ml

0.79

505

(3011335) Digoxin [Mass/volume] in Serum or Plasma

228

1.57

2.39

2.8

2.1

—

(36303858) Crystals [Presence] in Urine

2.40

2.32

1.1

1.2

—

(3019174) dRVVT (LA screen)

319

1.47

2.31

1.1

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

267

1524

1.21

2.28

27.7

27.9

120.16

116.71

ug/l

0.30

219

1267

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.98

2.28

1.0

0.20

0.67

u/ml

1.25

(3004446) Plasmodium sp identified in Blood by Light microscopy

394

1.42

2.28

2.5

2.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

215

1.57

2.26

1.5

1.3

—

(40762814) Titanium [Mass/volume] in Blood

500

1.36

2.24

2.2

2.3

3.77

3.66

ug/l

0.06

165

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

189

1.60

2.22

1.4

1.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.21

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

256

1.51

2.17

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

182

1005

1.25

2.16

1.5

1.4

52.93

54.95

0.28

150

866

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

199

1111

1.23

2.14

1.1

1.0

8.87

11.02

u/ml

0.74

110

640

(3036005) Urine sediment comments by Light microscopy Narrative

2.58

2.13

1.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.44

2.13

1.0

1.1

27.50

31.12

umol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

253

1.50

2.08

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.04

2.07

1.5

2.5

2.10

2.12

mu/l

0.01

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

109

1.77

2.03

1.0

1.1

0.20

0.21

g/l

0.76

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

892

5590

1.10

2.02

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

233

1.51

2.01

5.6

5.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

289

2338

0.85

2.00

1.0

1.1

2.46

2.36

u/ml

0.02

568

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

239

1.50

1.99

3.7

2.3

—

(3024316) Viscosity of Plasma

157

1.62

1.99

1.5

1.8

1.76

1.64

mpas

0.39

(3013247) Albumin in CSF/Albumin in Serum or Plasma

145

789

1.27

1.98

1.1

6.45

7.10

mg/g

0.50

139

749

(3041806) Other cells [#/volume] in Blood by Manual count

196

1637

0.82

1.95

1.6

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

632

3902

1.12

1.93

1.2

1.1

96.79

95.49

0.58

582

3664

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

607

3748

1.12

1.87

2.3

—

(40765096) Chromosome analysis panel by Banding

159

882

1.24

1.86

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

128

1.67

1.86

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1099

6984

1.08

1.85

3.7

3.1

1.58

mmol/l

0.03

1074

6845

(3000060) B lymphocytes [#/volume] in Blood

177

994

1.23

1.85

1.8

2.1

177.92

819.67

e6/l

1.51

101

523

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

464

1.34

1.85

3.5

2.9

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.75

1.83

1.2

1.0

0.00

4.00

u/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

164

916

1.23

1.81

1.4

1.3

4.14

3.40

mmol/l

1.53

147

842

(40768795) Lymph node Pathology biopsy report

527

3235

1.12

1.81

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

35497

242074

1.02

1.77

3.4

3.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.80

1.73

1.4

1.6

108.08

124.86

ug/l

0.23

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

100

1.72

1.69

1.1

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

3.01

1.69

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.00

1.69

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

171

1.53

1.65

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

438

0.69

1.65

6.0

1.4

7.21

7.28

mmol/l

0.05

158

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

199

1.49

1.64

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

139

1176

0.81

1.63

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1921

12513

1.06

1.63

1.3

211.27

224.77

miu/ml

0.78

704

5986

(3001686) Cold agglutinin [Titer] in Serum or Plasma

106

572

1.28

1.61

1.2

1.3

77.08

168.25

titre

0.85

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

189

1.49

1.60

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

536

1.28

1.60

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

178

1.51

1.60

1.1

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

129

1.60

1.58

1.1

2.33

0.96

u/field

0.56

(3038177) Helicobacter pylori Ab [Presence] in Serum

952

6063

1.08

1.58

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

136

760

1.23

1.55

1.2

1.1

68.06

78.25

0.94

202

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

106

577

1.26

1.52

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

136

1.57

1.52

7.7

9.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

147

1.55

1.52

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.72

1.51

4.2

6.3

0.81

1.39

mg/l

1.88

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.74

1.50

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

104

1.65

1.50

1.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

2.68

1.50

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

439

1.30

1.49

1.3

1.68

1.28

mmol/l

0.26

274

(3007916) DNA double strand Ab [Titer] in Serum

427

1.31

1.49

1.2

1.4

46.80

149.39

titre

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

126

702

1.24

1.49

2.4

2.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

165

1.50

1.47

1.1

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.12

1.46

2.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

263

1570

1.15

1.45

34.9

36.6

7.26

7.39

ug/l

0.52

240

1429

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

282

1692

1.15

1.45

1.1

1603.55

1501.93

miu/ml

0.77

282

1692

(3033705) Calcium.ionized [Moles/volume] in Venous blood

614

3863

1.09

1.40

2.8

2.4

—

(3050794) Legionella sp Ab [Presence] in Serum

289

1.36

1.38

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

135

765

1.21

1.38

1.2

86.55

89.83

0.28

215

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

3.13

1.37

2.6

1.9

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.84

1.36

1.0

353.14

360.26

umol/l

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

140

799

1.21

1.34

1.2

1.3

112.55

107.37

0.97

132

754

(3004775) Volume in Urine collected for unspecified duration

420

2601

1.11

1.33

2.1

2.3

731.72

666.56

1.89

290

1778

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

304

1.34

1.30

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

223

1329

1.16

1.30

1.9

2.1

29.48

29.19

0.11

211

1256

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.70

1.28

1.0

—

1.01

—

(3020874) Milk IgE Ab [Units/volume] in Serum

306

2371

0.89

1.27

1.0

1.1

3.02

2.30

u/ml

0.12

102

753

(3011544) Albumin [Mass/volume] in Pleural fluid

276

1.35

1.27

1.1

18.07

17.13

g/l

0.37

248

(3032743) Legionella sp IgG Ab [Presence] in Serum

229

1.38

1.26

1.1

—

(3018133) Calcium [Moles/volume] in Urine

506

1.25

1.26

1.7

1.8

2.52

2.68

mmol/l

0.34

457

(3015350) Toxocara sp Ab [Presence] in Serum

2.05

1.25

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

373

1.29

1.24

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

178

1.43

1.23

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

260

1574

1.14

1.23

2.0

2.2

19.93

197.01

ug/l

1.85

245

1505

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

332

1.31

1.21

1.1

—

(3024932) HLA-DR beta [Type]

198

1178

1.16

1.20

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

375

1.28

1.20

1.3

36.73

265.15

u/l

1.15

268

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.18

0.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

598

4461

0.92

1.18

1.1

1.0

0.26

0.48

u/ml

1.07

170

1158

(21494567) Legionella sp IgM Ab [Presence] in Serum

238

1.36

1.18

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

256

1.34

1.18

1.0

1.1

14.33

18.35

iu/ml

0.18

(3024471) HLA-A [Type]

202

1206

1.15

1.18

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

324

1995

1.12

1.17

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

2.65

1.17

1.2

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

365

1.28

1.16

1.4

71.25

71.48

0.02

303

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

476

1.24

1.14

1.9

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

125

720

1.20

1.13

1.7

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

801

5149

1.07

1.13

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

170

1.42

1.13

1.5

1.6

183.17

180.44

ug/g

0.03

145

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

379

1.27

1.12

1.0

0.16

0.18

u/ml

0.12

229

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

176

1.41

1.12

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.04

1.12

1.0

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

225

1360

1.14

1.11

1.9

2.2

9.85

10.21

0.20

209

1260

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

255

1554

1.13

1.11

2.1

97.77

100.65

ug/min

0.02

360

(3032352) Blasts [#/volume] in Cerebral spinal fluid

337

1.29

1.11

1.8

2.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

435

1.25

1.11

1.1

1.0

—

(4212803) Bone marrow aspirate examination

271

1.32

1.10

1.0

1.1

—

(3006598) pH of Arterial cord blood

135

0.56

1.09

1.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

154

1.43

1.09

1.0

0.09

0.15

u/ml

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.46

1.08

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.46

1.08

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

158

1259

0.86

1.05

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

488

1.23

1.05

1.6

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

179

1.38

1.04

1.0

1.2

—

303.33

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

1.00

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

100

1.51

0.99

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.91

0.98

2.3

2.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

302

1.28

0.96

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

332

0.75

0.96

1.5

1.6

—

(40763590) HLA-DQ beta [Type]

124

1.44

0.95

1.0

—

(40760410) HLA-B [Type] by High resolution

125

1.43

0.92

1.0

—

(40760409) HLA-A [Type] by High resolution

125

1.43

0.92

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.17

0.91

1.2

29.32

29.46

nmol/24h

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.51

0.91

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

668

4311

1.07

0.90

2.4

2.5

—

(46236302) HLA-C [Type] by High resolution typing

126

1.42

0.89

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

625

4029

1.07

0.88

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

325

1.25

0.87

1.2

1.3

6.04

6.16

mmol/l

0.05

162

(3013862) HLA-DP [Type]

127

1.41

0.86

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

358

2262

1.09

0.85

1.1

8.23

8.42

iu/ml

0.05

597

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

139

1.39

0.85

1.0

0.11

0.07

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

844

6129

0.95

0.84

1.1

—

(3036603) Volume of Urine

363

2298

1.09

0.84

1.5

1.6

2044.89

1970.84

0.73

357

2229

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

490

1.19

0.83

1.7

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

874

1.14

0.82

1.9

2.0

35.19

37.99

u/l

0.09

134

783

(40763791) Oxygen content in Venous blood by calculation

1.49

0.82

4.9

7.7

11.67

12.36

ml/dl

0.28

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.81

0.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

155

941

1.13

0.79

1.6

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

147

1.36

0.79

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

756

5493

0.95

0.78

1.1

3.43

4.42

u/ml

1.05

357

2590

(3012494) Peanut IgE Ab [Units/volume] in Serum

173

1060

1.12

0.77

1.1

2.15

15.23

u/ml

0.75

596

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

220

1.28

0.77

1.0

0.47

1.89

u/ml

1.10

171

(3007733) Chloride [Moles/volume] in Urine

1.50

0.77

1.1

1.5

114.75

82.46

mmol/l

0.91

(3044416) Complement C4 [Mass/volume] in Pleural fluid

136

1.37

0.77

1.2

0.08

0.07

g/l

0.13

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

531

0.83

0.76

6.3

6.9

—

(3015183) Erythrocyte sedimentation rate

258

1945

0.91

0.75

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

371

2365

1.08

0.75

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

455

0.82

0.75

17.3

5.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

848

6129

0.95

0.74

1.1

—

(3000330) Specific gravity of Urine by Test strip

2464

16482

1.03

0.74

3.8

3.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.63

0.73

1.0

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.02

0.73

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.02

0.73

1.2

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.02

0.73

1.2

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.68

0.69

1.1

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.68

0.69

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.68

0.69

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.68

0.69

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.68

0.69

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.68

0.69

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.68

0.69

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.51

0.66

2.0

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

232

1.25

0.65

4.6

4.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

904

6495

0.96

0.64

1.1

0.66

1.16

u/ml

3.60

361

2726

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

226

0.76

0.64

1.1

1.0

5.64

7.76

u/ml

0.42

164

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

333

1.20

0.64

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.45

0.64

5.7

5.3

0.22

0.25

mmol/l

0.16

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

518

1.16

0.63

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.72

0.62

1.0

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

0.09

—

(3038515) Glucose [Moles/volume] in Venous blood

999

6609

1.04

0.60

3.9

3.2

7.44

7.57

mmol/l

0.69

977

6494

(3019768) Coxiella burnetii Ab [Presence] in Serum

198

1.25

0.60

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

716

5159

0.95

0.59

1.1

4.75

4.98

u/ml

0.11

305

2124

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

223

0.77

0.59

1.1

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.72

0.58

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

545

3560

1.05

0.58

1.3

1.4

9.11

8.09

mmol/l

5.39

520

3438

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

442

2874

1.06

0.56

1.4

1.3

157.98

186.23

pmol/l

1.84

442

2874

(3008607) Semen analysis panel

281

0.81

0.55

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1065

7591

0.96

0.54

1.1

1.57

2.06

u/ml

0.99

527

3799

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.59

0.54

2.0

2.7

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.47

0.54

1.4

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.47

0.53

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

411

1.16

0.53

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.44

0.53

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

891

6364

0.96

0.52

1.1

1.36

1.92

u/ml

1.59

468

3091

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

133

0.72

0.52

1.0

0.06

0.28

u/ml

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

625

0.88

0.51

4.7

5.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

216

1.21

0.49

3.6

2.6

21.88

13.57

1.31

(40758358) Immune stain study

142

1.26

0.48

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

960

6832

0.97

0.48

1.1

4.29

5.38

u/ml

1.47

479

3498

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.50

0.47

1.1

1791.00

2087.83

titre

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

199

1.21

0.46

4.7

5.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

113

703

1.11

0.46

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

113

703

1.11

0.46

1.2

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

130

0.74

0.46

1.0

0.13

0.47

u/ml

—

(3042733) HLA Ab [Presence] in Serum

193

1232

1.08

0.45

4.5

5.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.38

0.45

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

346

2253

1.06

0.45

1.1

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.41

0.42

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.42

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

616

1.11

0.42

1.1

1.08

4.58

u/ml

1.84

435

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

807

5371

1.03

0.42

1.1

2.32

2.96

u/ml

0.94

320

2705

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

112

702

1.10

0.41

1.2

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.31

0.40

10.0

8.2

39.63

44.65

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

448

1.12

0.40

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

115

724

1.09

0.39

2.8

2.6

114.01

98.50

ng/l

0.31

365

(3036071) Salmonella sp Ab [Titer] in Serum

182

1169

1.07

0.39

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

118

0.76

0.38

1.0

0.19

0.96

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

110

693

1.09

0.38

1.3

1.2

58.53

42.27

mg/l

0.14

503

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

319

2088

1.05

0.38

5.4

6.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.32

0.37

1.0

—

(3003577) Lead [Moles/volume] in Blood

282

0.85

0.37

1.2

1.5

0.16

0.23

umol/l

1.00

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

282

1.15

0.37

1.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.47

0.36

1.2

1.0

—

(3034426) Prothrombin time (PT)

189

1220

1.07

0.36

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.27

0.35

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

316

1.13

0.35

1.4

1.3

399.74

326.87

mg/24h

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

237

1721

0.95

0.34

1.2

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.33

0.34

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

703

0.92

0.32

10.4

8.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

247

1.14

0.32

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

273

1.13

0.32

2.3

2.5

732.20

314.85

umol/l

0.58

263

(3027231) Wheat IgE Ab [Units/volume] in Serum

738

0.92

0.31

1.0

1.1

1.32

1.07

u/ml

0.13

630

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

177

1.17

0.30

1.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.26

0.30

1.1

1.0

0.01

0.19

u/ml

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

200

1308

1.05

0.28

2.4

2.6

197.61

136.82

au/ml

0.92

183

(3035611) Eosinophils/100 leukocytes in Synovial fluid

224

1.14

0.28

1.8

1.7

0.62

0.73

0.16

173

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

633

1.08

0.27

2.0

1.8

2.15

3.56

ug/l

0.87

380

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

123

793

1.07

0.27

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

205

1.14

0.27

1.1

20.95

24.27

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

205

1.14

0.27

1.1

33.58

31.66

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

209

1509

0.95

0.27

1.2

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.22

0.26

10.4

8.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.26

0.26

1.9

3.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

103

0.80

0.25

1.1

—

(3020650) Glucose [Presence] in Urine

150

979

1.05

0.24

1.6

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

227

1.12

0.24

1.0

—

(3009992) Blasts/100 cells in Bone marrow

1.38

0.24

1.2

1.8

21.60

17.24

—

(3041672) Baker's yeast Ab [Presence] in Serum

162

1.15

0.24

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

359

1.09

0.23

1.0

0.07

0.41

u/ml

1.22

199

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

247

1.11

0.23

1.0

0.05

0.77

u/ml

1.12

159

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.32

0.23

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.25

0.23

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.19

0.23

1.1

1.3

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

116

0.83

0.22

1.0

0.15

0.12

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

455

0.92

0.22

1.1

1.0

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.6

—

4.08

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

118

1.17

0.21

1.1

208.27

275.47

nmol/l

1.67

118

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.23

0.21

1.1

1.3

0.68

7.37

mg/l

2.70

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

474

0.93

0.20

1.2

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

159

1046

1.05

0.20

1.7

149.24

128.64

au/ml

0.17

136

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

369

1.08

0.20

1.0

0.48

1.35

u/ml

0.40

200

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.21

0.20

1.2

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

204

1.11

0.20

1.1

1.2

1.56

4.06

u/ml

0.60

171

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

280

0.91

0.19

1.4

1.3

23.43

21.17

mmol/l

1.59

208

(40762887) Creatinine [Moles/volume] in Blood

1.21

0.19

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

398

1.07

0.18

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.22

0.18

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.17

0.18

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.17

0.18

1.0

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

410

2756

1.02

0.17

1.8

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

134

1.13

0.17

1.4

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

131

864

1.04

0.16

1.3

39.13

38.77

0.04

586

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

177

0.89

0.16

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.85

0.15

2.2

3.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.13

0.15

6.2

3.9

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

195

1300

1.03

0.15

2.0

8.88

9.32

mg/l

0.52

169

1028

(3009871) Measles virus Ab [Titer] in Serum

183

1219

1.03

0.15

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

308

2069

1.02

0.15

1.4

5.80

5.56

mmol/l

3.18

288

1959

(40768446) Kidney Pathology biopsy report

214

1430

1.03

0.15

1.6

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

118

0.87

0.14

1.8

2.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

112

803

0.96

0.14

10.2

8.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

176

1.09

0.13

15.1

9.4

232.75

308.08

e6/l

0.21

129

(3020356) Listeria sp identified in Specimen by Organism specific culture

274

0.93

0.13

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

505

1.05

0.13

2.6

2.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

217

0.92

0.13

1.0

30.15

16.76

u/ml

0.35

181

(3018291) Platelet Ab [Presence] in Serum

1.19

0.12

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

338

1.06

0.12

1.0

0.59

0.49

u/ml

0.07

190

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1021

7099

0.99

0.11

1.8

1.6

—

(40758292) HTLV I+II Ab panel - Serum

582

1.04

0.11

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

205

1.07

0.11

1.1

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.88

0.11

1.0

0.06

0.07

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

1.13

0.10

1.6

1.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

415

1.04

0.10

7.8

8.0

0.36

0.40

umol/l

0.21

375

(3010937) Rubella virus Ab [Presence] in Serum

235

0.94

0.10

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

180

1.07

0.09

4.2

3.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.12

0.09

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

156

0.93

0.08

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

715

4966

0.99

0.08

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

344

1.04

0.07

1.0

0.13

1.69

u/ml

2.46

258

(3022670) pH of Venous cord blood

0.85

0.07

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

165

1156

0.98

0.06

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

222

1506

1.01

0.06

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

129

1.07

0.05

1.3

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

258

1.04

0.05

1.1

1.0

0.14

0.76

u/ml

0.95

157

(3034614) HLA Ag [Interpretation]

1.09

0.05

1.3

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.91

0.05

1.6

1.4

2.24

2.14

mmol/24h

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

111

0.93

0.05

1.8

2.2

—

(3001729) Color of Synovial fluid

266

1.03

0.04

1.7

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

341

1.03

0.04

1.0

0.14

1.62

u/ml

1.58

258

(3036312) Salmon IgE Ab [Units/volume] in Serum

222

0.96

0.04

1.1

2.47

0.71

u/ml

0.67

150

(3006969) Lambda light chains [Mass/volume] in Urine

1.09

0.04

1.0

1.1

0.02

0.06

g/l

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

270

0.97

0.04

1.8

3.3

2.03

2.23

mg/l

0.29

229

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

383

1.02

0.03

2.4

2.5

25.45

22.27

mg/l

0.75

363

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

622

0.98

0.03

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

138

1.05

0.03

23.2

14.9

—

(3007542) Rye IgE Ab [Units/volume] in Serum

199

0.97

0.02

1.0

1.1

0.58

9.82

u/ml

0.49

(3007700) Barley IgE Ab [Units/volume] in Serum

173

1.03

0.02

1.0

0.06

8.55

u/ml

0.54

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

208

1441

0.99

0.02

3.0

3.1

8.74

7.84

mg/l

0.82

162

1158

(3016031) Almond IgE Ab [Units/volume] in Serum

247

0.98

0.02

1.1

1.0

0.07

0.68

u/ml

4.43

144

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

592

0.99

0.02

1.2

1.5

5.39

6.38

nmol/l

0.68

567

(3035933) Granulocytes/100 leukocytes in Blood

141

978

0.99

0.02

3.5

1.6

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.07

0.01

1.1

1.2

25.09

28.84

mg/l

0.45

(1761482) Bacteria [#/volume] in Urine by Culture

1214

8365

1.00

0.01

5.1

3.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.94

0.00

2.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

352

2418

1.00

0.00

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

211

1448

1.00

0.00

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

804

5537

1.00

0.00

1.9

2.1

6.49

6.57

umol/l

0.06

571

4039

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

375

1.01

0.00

2.4

2.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

154

1061

1.00

0.00

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

206

1.00

0.00

1.5

2.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

401

1.00

0.00

1.9

1.7

1.65

1.70

mg/l

0.09

336

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.02

0.00

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

202

0.99

0.00

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

230

0.99

0.00

1.4

1.5

340.45

323.63

umol/24h

0.12

230

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.00

-0.00

1.0

1.1

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.46

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.86

-0.00

1.5

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_BZD – Benzodiazepine use

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benzodiazepine use

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Benzodiazepine use (RX_BZD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints